Pontocerebellar Hypoplasia

Mendelian MONDO:0020135 Pathograph 46 Show in embeddings browser Neurodegenerative Disease Cerebellar Hypoplasia

Pontocerebellar hypoplasia (PCH) is a clinically and genetically heterogeneous group of autosomal recessive neurodegenerative disorders characterized by prenatal-onset hypoplasia and progressive atrophy of the cerebellum and ventral pons, severe intellectual disability, limited motor development, and variable extra-neural features. PCH is divided into numbered subtypes, each defined by its causal gene; most of the genes function in RNA processing or translation, the tRNA splicing endonuclease (TSEN) complex and the RNA exosome being the largest groups among the subtypes curated here, and PCH2 (TSEN54) is the most common form. Several subtypes fall outside that theme entirely: PCH3 is a presynaptic active zone defect (PCLO), PCH8 an ESCRT-III defect in which cerebellar progenitors fail to proliferate (CHMP1A), PCH11 a Golgi retrograde-trafficking defect (TBC1D23), PCH9, PCH12 and PCH16 metabolic enzyme deficiencies (AMPD2, COASY, MINPP1), PCH1E a mitochondrial dynamics defect (SLC25A46), and PCH17 a failure of cerebellar GABAergic neuron specification (PRDM13). No disease-modifying therapy exists and management remains supportive.

Ask OpenScientist

Ask a research question about Pontocerebellar Hypoplasia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

👪

Inheritance

Autosomal recessive HP:0000007

All major PCH forms show autosomal recessive inheritance. Most cases result from homozygous founder mutations (e.g., TSEN54 A307S in PCH2) or compound heterozygous loss-of-function alleles.

Autosomal recessive inheritance

Show evidence (3 references)

PMID:21749694 SUPPORT Human Clinical

"Pontocerebellar Hypoplasia (PCH) is group of very rare, inherited progressive neurodegenerative disorders with prenatal onset."

Review confirming PCH as an inherited neurodegenerative group, consistent with autosomal recessive inheritance established across all subtypes.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"TSEN54-PCH is inherited in an autosomal recessive manner."

GeneReviews states the recessive inheritance of the largest PCH subtype group directly.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"If both parents are known to be heterozygous for a TSEN54 pathogenic variant, each sib of an affected individual has at conception a 25% chance of inheriting both pathogenic variants and being affected, a 50% chance of inheriting one pathogenic variant and being an unaffected carrier, and a 25%..."

Gives the recurrence risks that follow from the recessive mode recorded here.

◆

Subtypes

PCH Type 1A (VRK1) MONDO:0011866

VRK1 hgnc:12718

Pontocerebellar hypoplasia type 1A caused by biallelic VRK1 mutations. Characterized by cerebellar and pontine hypoplasia combined with anterior horn cell degeneration (resembling spinal muscular atrophy), severe hypotonia, and respiratory insufficiency. MONDO:0011866.

Show evidence (1 reference)

PMID:19646678 SUPPORT Human Clinical

"identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"

Establishes VRK1 as the causal gene for the SMA-PCH/PCH1A subtype.

PCH Type 1B (EXOSC3) MONDO:0013853

EXOSC3 hgnc:17944

Pontocerebellar hypoplasia type 1B caused by biallelic EXOSC3 mutations. This PCH1 subtype combines pontocerebellar hypoplasia with spinal muscular atrophy-like weakness, profound developmental impairment, and variable survival.

Show evidence (2 references)

PMID:23284067 SUPPORT Human Clinical

"EXOSC3 mutations account for 30%-40% of patients with PCH1 with variability in survival and clinical severity that is correlated with the genotype."

Establishes EXOSC3 as a major cause of PCH1, corresponding to the PCH1B subtype.

PMID:25144110 SUPPORT REVIEW SYNTHESIS Human Clinical

"EXOSC3 pontocerebellar hypoplasia (EXOSC3-PCH) is characterized by abnormalities in the posterior fossa and degeneration of the anterior horn cells."

GeneReviews chapter for the EXOSC3 form of PCH, confirming the anterior horn cell involvement that defines the PCH1 group.

PCH Type 2 (TSEN54) MONDO:0016759

TSEN54 hgnc:27561

The most common form of PCH, caused by TSEN54 mutations (most commonly the A307S founder allele). Characterized by progressive microcephaly, dyskinesia, and seizures with relative preservation of the brainstem. This row is the PCH2 group term; the gene-specific forms are enumerated separately as PCH2A (TSEN54), PCH2B (TSEN2), PCH2C (TSEN34) and PCH2F (TSEN15). PCH2D is caused by SEPSECS and PCH2E by VPS53; neither is curated on this entry, and VPS53-related PCH2E has its own dismech entry. MONDO:0016759.

Show evidence (1 reference)

PMID:20952379 SUPPORT Human Clinical

"Mutations in the transfer RNA splicing endonuclease subunit genes (TSEN54, TSEN2, TSEN34) were found to be associated with pontocerebellar hypoplasia types 2 and 4."

Supports TSEN-complex mutation association with PCH2 and grounds TSEN54 as the most common PCH2 gene in this entry.

PCH Type 4 (TSEN54, severe) MONDO:0009166

TSEN54 hgnc:27561

Severe form caused by biallelic TSEN54 null or severe compound heterozygous alleles. Neonatal lethal with generalized clonus, olivopontocerebellar hypoplasia, and respiratory failure. MONDO:0009166.

Show evidence (1 reference)

PMID:20952379 SUPPORT Human Clinical

"Nonsense or splice site mutations in TSEN54 are associated with a more severe phenotype of more perinatal symptoms, ventilator dependency and early death."

Supports the severe neonatal/early lethal PCH4 phenotype associated with null or splice-site TSEN54 alleles.

PCH Type 6 (RARS2) MONDO:0012683

RARS2 hgnc:21406

Caused by mutations in RARS2, encoding mitochondrial arginyl-tRNA synthetase. Features cerebellar and pontine hypoplasia, severe intellectual disability, epilepsy, and elevated CSF lactate reflecting mitochondrial dysfunction. MONDO:0012683.

Show evidence (1 reference)

PMID:22569581 SUPPORT Human Clinical

"Recessive mutations in the mitochondrial arginyl-transfer RNA synthetase (RARS2) gene have been associated with early onset encephalopathy with signs of oxidative phosphorylation defects classified as pontocerebellar hypoplasia 6."

Establishes RARS2 mutations as the molecular basis of PCH6.

PCH Type 10 (CLP1) MONDO:0014349

CLP1 hgnc:16999

Pontocerebellar hypoplasia type 10 caused by biallelic CLP1 mutations. CLP1 interacts with the TSEN complex in tRNA splicing, and affected individuals can have severe motor-sensory defects, microcephaly, seizures, cortical dysgenesis, and peripheral neuropathy.

Show evidence (1 reference)

PMID:24766809 SUPPORT Human Clinical

"A parallel study (Schaffer et al. this issue) reported CLP1 mutation in association with a clinical phenotype of pontocerebellar hypoplasia; they also report a R140H founder mutation."

Supports CLP1 mutation as a pontocerebellar hypoplasia subtype mechanism, corresponding to PCH10.

PCH Type 1C (EXOSC8) MONDO:0014485

EXOSC8 hgnc:17035

Pontocerebellar hypoplasia type 1C is the EXOSC8-associated form of PCH1. EXOSC8 encodes a structural subunit of the RNA exosome, the same complex whose EXOSC3 subunit underlies PCH1B, so PCH1C shares the PCH1 pattern of pontocerebellar hypoplasia with anterior horn cell degeneration and spinal muscular atrophy-like weakness.

Show evidence (2 references)

PMID:33463720 SUPPORT BACKGROUND Human Clinical

"Bi-allelic variants in exosome subunits EXOSC3, EXOSC8 and EXOSC9 have been reported to cause pontocerebellar hypoplasia type 1B, type 1C and type 1D, respectively, while those in EXOSC2 cause short stature, hearing loss, retinitis pigmentosa and distinctive facies."

States that biallelic EXOSC8 variants cause pontocerebellar hypoplasia type 1C, the gene-disease assignment this subtype row records.

PMID:40428407 SUPPORT REVIEW SYNTHESIS Human Clinical

"PCH1 is defined as PCH variant associated with anterior horn degeneration in the spinal cord with muscle weakness and hypotonia, and is associated with recessive variants in genes VRK1, EXOSC3, EXOSC8, EXOSC9 and SLC25A46."

Places EXOSC8 among the recessive PCH1 genes and states the anterior horn cell involvement that defines the PCH1 group.

PCH Type 1D (EXOSC9) MONDO:0054844

EXOSC9 hgnc:9137

Pontocerebellar hypoplasia type 1D is the EXOSC9-associated form of PCH1. EXOSC9 is a third structural RNA exosome subunit in which biallelic variants produce cerebellar atrophy together with spinal motor neuronopathy, the PCH1 phenotype pattern.

Show evidence (2 references)

PMID:33463720 SUPPORT BACKGROUND Human Clinical

States that biallelic EXOSC9 variants cause pontocerebellar hypoplasia type 1D.

PMID:31768969 SUPPORT REVIEW SYNTHESIS Human Clinical

"mutations in the structural exosome gene EXOSC9 cause a PCH-like disease with cerebellar atrophy and spinal motor neuronopathy."

Describes the EXOSC9 phenotype as cerebellar atrophy with spinal motor neuronopathy, the clinical content of this row.

PCH Type 1E (SLC25A46) MONDO:0030260

SLC25A46 hgnc:25198

Pontocerebellar hypoplasia type 1E is the SLC25A46-associated form of PCH1. SLC25A46 encodes a mitochondrial outer-membrane protein of the fission and fusion machinery rather than an RNA-processing factor, so PCH1E reaches the PCH1 phenotype by a mechanism distinct from the RNA exosome subtypes. Loss of function was first reported in neonatally lethal pontocerebellar hypoplasia with apnoea; milder SLC25A46 alleles cause optic atrophy and peripheral neuropathy.

Show evidence (2 references)

PMID:27543974 SUPPORT Human Clinical

"In siblings from two unrelated families who died soon after birth with a profound neurodevelopmental disorder characterized by pontocerebellar hypoplasia and apnoea, we discovered a missense mutation and an exonic deletion in the SLC25A46 gene encoding a mitochondrial protein recently implicated..."

Reports the biallelic SLC25A46 lesions in lethal congenital pontocerebellar hypoplasia that define this subtype.

PMID:40428407 SUPPORT REVIEW SYNTHESIS Human Clinical

Places SLC25A46 among the recessive PCH1 genes.

PCH Type 2A (TSEN54) MONDO:0010190

TSEN54 hgnc:27561

Pontocerebellar hypoplasia type 2A is the TSEN54-associated form of PCH2, which is the most frequently reported and best studied PCH subtype. It sits alongside PCH4 and PCH5 as one of three TSEN54 phenotypes that differ mainly in life expectancy. Children with PCH2 carry an increased risk of rhabdomyolysis during severe infections, which is the one point in PCH management where a specific preventive measure applies.

Show evidence (2 references)

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings."

GeneReviews groups PCH2, PCH4 and PCH5 as the three TSEN54 phenotypes, which is the gene assignment this row records.

PMID:21749694 SUPPORT REVIEW SYNTHESIS Human Clinical

"PCH type 2 (PCH2, ORPHA2524, MIM 277470, 612389, 612390) is the most frequently reported and therefore the best studied subtype"

Sources the statement that PCH2 is the most frequently reported and best studied subtype.

PCH Type 2B (TSEN2) MONDO:0012890

TSEN2 hgnc:28422

Pontocerebellar hypoplasia type 2B is the TSEN2-associated form of PCH2. TSEN2 encodes a catalytic subunit of the same tRNA splicing endonuclease complex as TSEN54, and PCH2B is far rarer than the TSEN54 form.

Show evidence (2 references)

PMID:41621844 SUPPORT REVIEW SYNTHESIS Human Clinical

"Literature review has identified six PCH2B patients with missense, nonsense, frameshift, and splice site variants of the TSEN2 gene."

Assigns TSEN2 variants to PCH2B and indicates how few cases have been reported.

PMID:20803644 SUPPORT BACKGROUND Human Clinical

"Most patients with PCH2 have mutations in TSEN54, with occasional mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA splicing endonuclease."

Supports TSEN2 as an infrequent PCH2 gene relative to TSEN54.

PCH Type 2C (TSEN34) MONDO:0012891

TSEN34 hgnc:15506

Pontocerebellar hypoplasia type 2C is the TSEN34-associated form of PCH2. TSEN34 encodes the second catalytic subunit of the tRNA splicing endonuclease complex; like TSEN2, it accounts for only occasional PCH2 cases.

Show evidence (1 reference)

PMID:20803644 SUPPORT BACKGROUND Human Clinical

"Most patients with PCH2 have mutations in TSEN54, with occasional mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA splicing endonuclease."

Assigns TSEN34 to PCH2 as an infrequent cause, the gene-disease claim behind this row.

PCH Type 2F (TSEN15) MONDO:0014874

TSEN15 hgnc:16791

Pontocerebellar hypoplasia type 2F is the TSEN15-associated form of PCH2. TSEN15 is the fourth subunit of the tRNA splicing endonuclease complex, and the reported TSEN15 phenotype is milder than the TSEN54 form of PCH2.

Show evidence (1 reference)

PMID:27392077 SUPPORT Human Clinical

"Here, we report three homozygous TSEN15 variants that cause a milder version of PCH2."

Reports the biallelic TSEN15 variants that define this PCH2 subtype and its relatively milder course.

PCH Type 3 (PCLO) MONDO:0011948

PCLO hgnc:13406

Pontocerebellar hypoplasia type 3, historically called cerebellar atrophy with progressive microcephaly, is caused by biallelic loss of PCLO. PCLO encodes Piccolo, a presynaptic active zone scaffold protein, so PCH3 is a synaptic rather than an RNA-processing mechanism.

Show evidence (1 reference)

PMID:25832664 SUPPORT Human Clinical

"Here, we show that a homozygous, nonsense PCLO mutation underlies the autosomal recessive neurodegenerative disorder, PCH3."

Establishes biallelic PCLO loss of function as the cause of PCH3.

PCH Type 5 (TSEN54, fetal onset) MONDO:0012438

TSEN54 hgnc:27561

Pontocerebellar hypoplasia type 5 is a fetal-onset TSEN54 phenotype that overlaps PCH4 clinically and genotypically, with seizure-like activity in utero and early postnatal death. It is one of the three TSEN54 phenotypes recognised in GeneReviews and has been described in a single family.

Show evidence (3 references)

PMID:21368912 SUPPORT Human Clinical

"The PCH5 patient was found to be the result of compound heterozygosity for the common TSEN54 mutation (p.A307S) plus a novel splice site mutation."

Assigns the PCH5 phenotype to compound heterozygous TSEN54 alleles including the common p.A307S variant.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and neurologic findings."

Places PCH5 among the three TSEN54 phenotypes, which differ mainly in life expectancy.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"PCH5 resembles PCH4 and has been described in one family."

Sources the single-family report and the clinical overlap with PCH4 stated in this row.

PCH Type 7 (TOE1) MONDO:0013993

TOE1 hgnc:15954

Pontocerebellar hypoplasia type 7 is caused by biallelic TOE1 variants and is distinguished from other PCH subtypes by genital abnormality, presenting as PCH with a 46,XY disorder of sex development in individuals with an XY karyotype. TOE1 is a deadenylase acting on small nuclear RNAs.

Show evidence (2 references)

PMID:38605133 SUPPORT BACKGROUND Human Clinical

"Biallelic TOE1 variants can cause pontocerebellar hypoplasia type 7 (PCH7), a condition characterized by pontocerebellar hypoplasia with genital abnormality."

States the TOE1-PCH7 assignment and the genital feature that distinguishes this subtype.

PMID:42178111 SUPPORT BACKGROUND Other

"The Target of EGR1 (TOE1) gene encodes the TOE1 deadenylase, which is essential for the maturation of Pol-II transcribed snRNAs in humans."

Sources the deadenylase and snRNA maturation role of TOE1 stated in this row.

PCH Type 8 (CHMP1A) MONDO:0013990

CHMP1A hgnc:8740

Pontocerebellar hypoplasia type 8 is caused by biallelic loss of function of CHMP1A, a member of the ESCRT-III membrane-remodelling complex. The reported phenotype combines reduced cerebellar size with microcephaly, and the mechanism the cited sources tie to that reduction is failed proliferation of cortical and cerebellar progenitors.

Show evidence (1 reference)

PMID:23023333 SUPPORT Human Clinical

"Here, we show that loss-of-function mutations in human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral cortical size (microcephaly)."

Establishes biallelic CHMP1A loss of function as a cause of pontocerebellar hypoplasia with microcephaly.

PCH Type 9 (AMPD2) MONDO:0014351

AMPD2 hgnc:469

Pontocerebellar hypoplasia type 9 is caused by biallelic AMPD2 variants. AMPD2 encodes adenosine monophosphate deaminase 2, a purine-metabolism enzyme; variants that spare some isoforms have instead been reported in spastic paraplegia type 63, so the AMPD2 phenotype depends on which isoforms are affected.

Show evidence (2 references)

PMID:29463858 SUPPORT Human Clinical

"We identified homozygous or compound heterozygous AMPD2 variants in eight PCH-affected individuals from six families."

Reports the biallelic AMPD2 genotypes in PCH-affected individuals that define this subtype.

PMID:29463858 SUPPORT Human Clinical

"The existence of various AMPD2 isoforms with different functions possibly explains the variability in phenotypes associated with AMPD2 variants: variants leaving some of the isoforms intact may cause SPG63, while those affecting all isoforms may result in the severe and early-onset PCH9."

Supports the isoform-dependent split between AMPD2-related SPG63 and PCH9 noted in the description.

PCH Type 11 (TBC1D23) MONDO:0054669

TBC1D23 hgnc:25622

Pontocerebellar hypoplasia type 11 is caused by biallelic TBC1D23 variants. TBC1D23 is a Golgi-localised trafficking adaptor, and PCH11 has been reported as a non-degenerative PCH subtype, setting it apart from the progressive TSEN and RNA exosome forms.

Show evidence (2 references)

PMID:40581672 SUPPORT BACKGROUND Human Clinical

"Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive disorder caused by variants in TBC1D23."

States the TBC1D23-PCH11 gene-disease assignment recorded by this row.

PMID:28823706 SUPPORT Human Clinical

"Here, we report biallelic TBC1D23 mutations in six individuals from four unrelated families manifesting a non-degenerative form of PCH."

Sources the non-degenerative character of PCH11 stated in this row.

PCH Type 12 (COASY) MONDO:0032643

COASY hgnc:29932

Pontocerebellar hypoplasia type 12 is caused by biallelic COASY variants. COASY encodes CoA synthase, which catalyses the final steps of coenzyme A biosynthesis; near-complete loss of function gives the perinatal lethal PCH12 phenotype, while hypomorphic alleles cause COASY protein-associated neurodegeneration.

Show evidence (2 references)

PMID:35499143 SUPPORT BACKGROUND Human Clinical

"Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal neurodegenerative genetic disorder caused by biallelic mutations in the COASY gene."

States the COASY-PCH12 assignment and the perinatal lethal course.

PMID:39301217 SUPPORT BACKGROUND Human Clinical

"Recessive variants of this gene cause an exceptionally rare and devastating disease called COASY protein-associated neurodegeneration (CoPAN) while complete loss-of-function variants in COASY have been identified in fetuses/neonates with Pontocerebellar Hypoplasia type 12 (PCH 12)."

Supports the allele-severity split between PCH12 and COASY protein-associated neurodegeneration.

PCH Type 14 (PPIL1) MONDO:0030258

PPIL1 hgnc:9260

Pontocerebellar hypoplasia type 14 is caused by biallelic PPIL1 variants. PPIL1 is a component of the major spliceosome, and the reported phenotype is pontocerebellar hypoplasia with microcephaly.

Show evidence (1 reference)

PMID:33220177 SUPPORT Human Clinical

"Patients harbored biallelic mutations in genes encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17 (PRP17)."

Establishes biallelic PPIL1 variants as a cause of pontocerebellar hypoplasia with microcephaly.

PCH Type 16 (MINPP1) MONDO:0030438

MINPP1 hgnc:7102

Pontocerebellar hypoplasia type 16 is caused by biallelic MINPP1 variants. MINPP1 is a multiple inositol polyphosphate phosphatase whose loss allows the chelator inositol hexakisphosphate to accumulate intracellularly.

Show evidence (1 reference)

PMID:40508022 SUPPORT BACKGROUND Human Clinical

"Multiple subtypes of PCH have been identified, among which the rare subtype PCH type 16 is caused by MINPP1 genetic variants."

States the MINPP1-PCH16 gene-disease assignment recorded by this row.

PCH Type 17 (PRDM13) MONDO:0030890

PRDM13 hgnc:13998

Pontocerebellar hypoplasia type 17 is caused by biallelic PRDM13 variants. PRDM13 is a transcriptional repressor acting downstream of PTF1A in the cerebellar ventricular zone, and the reported phenotype is fatal perinatal brainstem dysfunction with cerebellar hypoplasia and a sparse, disorganised Purkinje cell layer. A separate PRDM13 phenotype combines cerebellar dysfunction with hypogonadotropic hypogonadism.

Show evidence (2 references)

PMID:35390279 SUPPORT Human Clinical

"We describe four families with children presenting with severe neonatal brainstem dysfunction and pronounced deficits in cognitive and motor development associated with four different bi-allelic mutations in PRDM13, including homozygous truncating variants in the most severely affected individuals."

Reports the biallelic PRDM13 lesions in a PCH-like perinatal phenotype, the basis of this subtype row.

PMID:34730112 SUPPORT Human Clinical

"Patients exhibited intellectual disability, ataxia with cerebellar hypoplasia, scoliosis, and delayed puberty with congenital hypogonadotropic hypogonadism (CHH)."

Sources the separate PRDM13 phenotype combining cerebellar dysfunction with hypogonadotropic hypogonadism mentioned in this row.

⚙

Pathophysiology

TSEN/CLP1 Dysfunction and Impaired Pre-tRNA Splicing

The tRNA splicing endonuclease (TSEN) complex, composed of TSEN2, TSEN15, TSEN34, and TSEN54, cleaves introns from pre-tRNA molecules at the canonical anticodon loop position. Mutations in TSEN54 (and other TSEN subunits) impair pre-tRNA processing, reducing the pool of mature, functional tRNAs available for translation. Developing pontocerebellar neurons have exceptionally high translational demands and are disproportionately vulnerable. This mechanism maps primarily to PCH2/PCH4 for TSEN genes and to PCH10 for CLP1. The TSEN complex also interacts with CLP1, an RNA kinase, reinforcing RNA-processing as the central pathogenic pathway.

neural stem cell CL:0000047 Purkinje cell CL:0000121 cerebellar granule cell CL:0001031

TSEN54 hgnc:27561 TSEN2 hgnc:28422 TSEN34 hgnc:15506 TSEN15 hgnc:16791 CLP1 hgnc:16999

tRNA splicing via endonucleolytic cleavage and ligation GO:0006388 ↓ DECREASED translation GO:0006412 ↓ DECREASED

Experimental models

PCH2A Patient-Derived Regional Neural Organoids ORGANOID Recapitulates TSEN54-related, brain-region-specific organoid growth reduction and altered neural progenitor proliferation.

Downstream

Dyskinesia TSEN54-related disease is the PCH form in which dyskinesia and dystonia are the characteristic movement disorder.

Respiratory Insufficiency Severe TSEN54 genotypes carry perinatal respiratory failure and ventilator dependency.

Impaired Cerebellar Development and Progressive Degeneration TSEN-complex defects converge on prenatal pontocerebellar maldevelopment with progressive atrophy.

Show evidence (4 references)

PMID:18711368 SUPPORT Human Clinical

"In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex."

Directly establishes that TSEN complex subunit mutations cause PCH2 and PCH4, linking impaired tRNA splicing to disease.

PMID:18711368 SUPPORT Human Clinical

"Our findings point to RNA processing as a new basic cellular impairment in neurological disorders."

Supports RNA processing deficiency as the central pathogenic mechanism in TSEN-related PCH.

PMID:21749694 SUPPORT Human Clinical

"Mutations in three tRNA splicing endonuclease subunit genes were found to be responsible for PCH2, PCH4 and PCH5."

Corroborates TSEN complex dysfunction as the molecular basis for the most common PCH subtypes.

+ 1 more reference

RNA Exosome Dysfunction (PCH1B/1C/1D)

Biallelic mutations in the structural subunits of the nine-subunit RNA exosome impair RNA processing and turnover and cause the PCH1 subtypes: EXOSC3 gives PCH1B, EXOSC8 gives PCH1C, and EXOSC9 gives PCH1D. This mechanism produces pontocerebellar hypoplasia with spinal muscular atrophy-like weakness and global developmental delay, but survival and clinical severity vary by genotype. In zebrafish and human cell models, loss of exosome subunits stabilises p53 and perturbs ribosome biogenesis, which has been proposed as the route from exosome deficiency to the neuronal loss seen in PCH1.

motor neuron CL:0000100 cerebellar granule cell CL:0001031

EXOSC3 hgnc:17944 EXOSC8 hgnc:17035 EXOSC9 hgnc:9137

RNA processing GO:0006396 ↓ DECREASED RNA catabolic process GO:0006401 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration RNA exosome subunit loss converges on pontocerebellar hypoplasia and progressive neurodevelopmental impairment.

Show evidence (6 references)

PMID:23284067 SUPPORT Human Clinical

"Pontocerebellar hypoplasia with spinal muscular atrophy, also known as PCH1, is a group of autosomal recessive disorders characterized by generalized muscle weakness and global developmental delay commonly resulting in early death."

Defines the PCH1 clinical pattern to which EXOSC3-related PCH1B belongs.

PMID:23284067 SUPPORT Human Clinical

"Biallelic mutations in EXOSC3 were detected in 10 of 27 families (37%)."

Establishes biallelic EXOSC3 variants as a recurrent cause of PCH1/PCH1B.

PMID:33463720 SUPPORT BACKGROUND Human Clinical

Assigns all three structural exosome subunits bound on this node to their respective PCH1 subtypes.

+ 3 more references

Mitochondrial tRNA Synthetase Deficiency (PCH6/RARS2)

Mutations in RARS2, encoding the mitochondrial arginyl-tRNA synthetase, reduce aminoacylation of mitochondrial tRNA-Arg. This impairs mitochondrial translation, decreases oxidative phosphorylation capacity, and leads to energy failure preferentially in high-metabolic-demand cells of the developing cerebellum and pons. Elevated CSF lactate and reduced respiratory chain complex activity are biochemical hallmarks.

Purkinje cell CL:0000121 cerebellar granule cell CL:0001031

RARS2 hgnc:21406

mitochondrial translation GO:0032543 ↓ DECREASED tRNA aminoacylation for mitochondrial protein translation GO:0070127 ↓ DECREASED

Downstream

Lactic Acidosis Impaired mitochondrial translation raises blood and CSF lactate, the biochemical signature that separates PCH6 from the RNA-processing subtypes.

Impaired Cerebellar Development and Progressive Degeneration RARS2-related mitochondrial translation defects are associated with progressive pontocerebellar and cortical atrophy.

Show evidence (3 references)

PMID:17847012 SUPPORT Human Clinical

"identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase"

First identification of RARS2 mutations causing PCH, establishing the mitochondrial tRNA synthetase deficiency mechanism.

PMID:17847012 SUPPORT Human Clinical

"The mutation was associated with the production of an abnormally short RARS2 transcript and a marked reduction of the mitochondrial tRNA(Arg) transcript in the patients' fibroblasts."

Mechanistically links RARS2 mutation to reduced mitochondrial tRNA charging, impairing mitochondrial translation.

PMID:22569581 SUPPORT Human Clinical

"Blood and CSF lactate was abnormally elevated in all five patients at early stages"

Elevated lactate is a biochemical signature of impaired mitochondrial oxidative phosphorylation due to RARS2 deficiency in PCH6.

Anterior Horn Cell Degeneration (PCH1A/VRK1)

In PCH1A, biallelic VRK1 loss-of-function mutations impair nuclear envelope formation and RNA processing in post-mitotic neurons. Motor neurons of the anterior horn of the spinal cord are additionally affected beyond pontocerebellar neurons, producing a spinal muscular atrophy-like clinical picture (hypotonia, muscle weakness, areflexia) superimposed on pontocerebellar hypoplasia.

motor neuron CL:0000100

VRK1 hgnc:12718

nuclear envelope organization GO:0006998 ↓ DECREASED translation GO:0006412 ↓ DECREASED

Downstream

Hypotonia Anterior horn cell loss produces the muscle weakness and hypotonia that define the SMA-like component of PCH1.

Impaired Cerebellar Development and Progressive Degeneration VRK1-associated SMA-PCH combines anterior horn cell degeneration with pontocerebellar hypoplasia.

Show evidence (2 references)

PMID:19646678 SUPPORT Human Clinical

"identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"

Establishes VRK1 loss-of-function as the causative mutation in PCH1A, which combines pontocerebellar hypoplasia with anterior horn cell degeneration.

PMID:19646678 SUPPORT Human Clinical

"VRK1, one of three members of the mammalian VRK family, is a serine/threonine kinase that phosphorylates p53 and CREB and is essential for nuclear envelope formation."

VRK1's role in nuclear envelope formation explains its neuronal vulnerability phenotype in PCH1A.

Spliceosome and snRNA Maturation Failure

Two PCH genes act on the maturation and function of small nuclear RNAs and the major spliceosome rather than on tRNA. TOE1 is a deadenylase that trims snRNA 3' ends, and PPIL1 is a peptidyl-prolyl isomerase component of the spliceosome. These are two steps in one pathway rather than two categories: the snRNAs TOE1 matures are components of the spliceosome PPIL1 belongs to, so biallelic loss of either gene converges on the same defect, loss of splicing integrity in developing neurons, giving PCH7 and PCH14 respectively.

TOE1 hgnc:15954 PPIL1 hgnc:9260

snRNA processing GO:0016180 ↓ DECREASED mRNA splicing, via spliceosome GO:0000398 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Failure of snRNA maturation and spliceosome function in developing hindbrain neurons converges on the shared pontocerebellar endpoint.

Show evidence (3 references)

PMID:42178111 SUPPORT BACKGROUND Human Clinical

"Over a dozen missense mutations in the TOE1 gene have been linked to Pontocerebellar Hypoplasia Type seven (PCH7), a rare but serious neurodevelopmental and neurodegenerative disease that leads to early mortality."

Links TOE1 ribonuclease variants to PCH7, one of the two subtypes this node groups.

PMID:33220177 SUPPORT Human Clinical

"Patients harbored biallelic mutations in genes encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17 (PRP17)."

Identifies PPIL1 as a spliceosome component mutated in pontocerebellar hypoplasia with microcephaly.

PMID:33220177 SUPPORT Model Organism

"Loss of either protein affected splicing integrity, predominantly affecting short and high GC-content introns and genes involved in brain disorders."

Supports impaired splicing integrity as the shared molecular consequence asserted by this node.

ESCRT-III Dysfunction and Impaired Progenitor Proliferation

CHMP1A is a subunit of the ESCRT-III membrane-remodelling complex. In null mice, loss of Chmp1a impairs intraluminal vesicle formation in multivesicular bodies and Sonic hedgehog secretion, and the cortical and cerebellar progenitors fail to proliferate; in patient cells the proliferation defect tracks increased INK4A expression and loss of its normal BMI1 repression. Biallelic loss of function gives PCH8. The proliferation arm rather than the trafficking arm is what the cited sources tie to reduced cerebellar size, so this node is kept separate from the TBC1D23 Golgi node.

CHMP1A hgnc:8740

multivesicular body assembly GO:0036258 ↓ DECREASED neural precursor cell proliferation GO:0061351 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Failure of cortical and cerebellar progenitor proliferation converges on the shared pontocerebellar endpoint.

Show evidence (5 references)

PMID:23023333 SUPPORT Human Clinical

"Here, we show that loss-of-function mutations in human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral cortical size (microcephaly)."

Establishes CHMP1A loss of function as a cause of pontocerebellar hypoplasia.

PMID:23023333 SUPPORT In Vitro

"CHMP1A-mutant cells show impaired proliferation, with increased expression of INK4A, a negative regulator of stem cell proliferation."

Sources the impaired proliferation and INK4A derepression named in this node's description.

PMID:23023333 SUPPORT In Vitro

"Chromatin immunoprecipitation suggests loss of the normal INK4A repression by BMI in these cells."

Sources the loss of BMI1 repression of INK4A named in this node's description.

+ 2 more references

Golgi Trafficking Failure

TBC1D23 is a Golgi-localised adaptor that bridges endosome-derived vesicles to golgins during retrograde transport and is required for LKB1 signalling at the Golgi. Biallelic loss gives PCH11, which has been reported as a non-degenerative PCH subtype with postnatal rather than prenatal cerebellar change, setting it apart from the RNA-processing forms.

TBC1D23 hgnc:25622

retrograde transport, endosome to Golgi GO:0042147 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Loss of Golgi-directed retrograde trafficking converges on the shared pontocerebellar endpoint, though in this subtype the cerebellar change is reported as postnatal rather than prenatal.

Show evidence (5 references)

PMID:38413626 SUPPORT In Vitro

"TBC1D23, a Golgi-localized protein that is frequently mutated in the neurodevelopment disorder pontocerebellar hypoplasia (PCH), is specifically required for the LKB1 signaling at the Golgi."

Establishes TBC1D23 as a Golgi-localised protein mutated in PCH and names the signalling role stated in this node.

PMID:40581672 SUPPORT BACKGROUND Human Clinical

"Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive disorder caused by variants in TBC1D23."

Establishes the TBC1D23-PCH11 gene-disease assignment behind this node.

PMID:28823706 SUPPORT Human Clinical

"Here, we report biallelic TBC1D23 mutations in six individuals from four unrelated families manifesting a non-degenerative form of PCH."

Sources the non-degenerative character of PCH11 stated in this node.

+ 2 more references

Mitochondrial Membrane Dynamics Disruption

SLC25A46 encodes a mitochondrial outer-membrane protein that tunes mitochondrial fission and fusion. Complete loss of function gives the lethal congenital PCH1E phenotype, while milder alleles of the same gene cause optic atrophy and hereditary motor and sensory neuropathy, so the severity of the PCH phenotype tracks the severity of the allele.

SLC25A46 hgnc:25198

mitochondrial fusion GO:0008053 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Loss of mitochondrial membrane dynamics in developing hindbrain neurons converges on the shared pontocerebellar endpoint.

Show evidence (2 references)

PMID:27543974 SUPPORT Human Clinical

Reports the biallelic SLC25A46 lesions in lethal congenital pontocerebellar hypoplasia.

PMID:27543974 SUPPORT Human Clinical

"This genotype-phenotype correlation underscores the importance of SLC25A46 and fine tuning of mitochondrial fission and fusion in pontocerebellar hypoplasia and central neurodevelopment in addition to optic and peripheral neuropathy across the life span."

Names mitochondrial fission and fusion as the process this node asserts is disrupted.

Coenzyme A Biosynthesis Deficiency

COASY encodes CoA synthase, which carries out the last steps of de novo coenzyme A biosynthesis. Near-complete loss of function gives the perinatal lethal PCH12 phenotype, whereas hypomorphic COASY alleles cause COASY protein-associated neurodegeneration, a form of neurodegeneration with brain iron accumulation.

COASY hgnc:29932

coenzyme A biosynthetic process GO:0015937 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Failure of coenzyme A supply in the developing hindbrain converges on the shared pontocerebellar endpoint.

Show evidence (2 references)

PMID:35499143 SUPPORT BACKGROUND Human Clinical

"Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal neurodegenerative genetic disorder caused by biallelic mutations in the COASY gene."

Establishes biallelic COASY mutation as the cause of PCH12.

PMID:39301217 SUPPORT BACKGROUND Human Clinical

Supports the allele-severity split between PCH12 and COASY protein-associated neurodegeneration stated in this node.

Purine Nucleotide Metabolism Failure

AMPD2 encodes adenosine monophosphate deaminase 2, which converts AMP to IMP. Variants that disable all isoforms give the severe early-onset PCH9 phenotype, whereas variants that leave some isoforms intact have instead been reported in spastic paraplegia type 63.

AMPD2 hgnc:469

AMP catabolic process GO:0006196 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Loss of AMP deaminase activity in developing hindbrain neurons converges on the shared pontocerebellar endpoint.

Show evidence (2 references)

PMID:29463858 SUPPORT Human Clinical

"We identified homozygous or compound heterozygous AMPD2 variants in eight PCH-affected individuals from six families."

Establishes biallelic AMPD2 variants as a cause of pontocerebellar hypoplasia.

PMID:29463858 SUPPORT Human Clinical

Supports the isoform-dependent phenotype split stated in this node's description.

Inositol Polyphosphate Metabolism Failure

MINPP1 is a multiple inositol polyphosphate phosphatase. Biallelic loss of function allows the chelator inositol hexakisphosphate to accumulate inside cells, which has been proposed as the route to the PCH16 phenotype.

MINPP1 hgnc:7102

inositol phosphate catabolic process GO:0071545 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Accumulation of inositol hexakisphosphate in developing brain cells converges on the shared pontocerebellar endpoint.

Show evidence (2 references)

PMID:40508022 SUPPORT BACKGROUND Human Clinical

"Multiple subtypes of PCH have been identified, among which the rare subtype PCH type 16 is caused by MINPP1 genetic variants."

Establishes MINPP1 as the PCH16 gene.

PMID:33257696 SUPPORT In Vitro

"These data suggest the involvement of IP6-mediated chelation on Pontocerebellar Hypoplasia disease pathology and thereby highlight the critical role of MINPP1 in the regulation of human brain development and homeostasis."

Supports inositol hexakisphosphate accumulation as the proposed mechanism stated in this node.

Cerebellar GABAergic Neuron Specification Failure

PRDM13 is a transcriptional repressor expressed in progenitors of the cerebellar ventricular zone, which give rise to the cerebellar GABAergic neurons including Purkinje cells. Biallelic PRDM13 loss produces a PCH-like phenotype with hypoplasia of the inferior olive, dysplasia of the dentate nucleus, and a sparse, disorganised Purkinje cell layer, so the lesion here is a failure of neuronal specification rather than of a housekeeping process.

PRDM13 hgnc:13998

GABAergic neuron differentiation GO:0097154 ↓ DECREASED cerebellar Purkinje cell differentiation GO:0021702 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Failure to specify cerebellar GABAergic neurons converges on the shared pontocerebellar endpoint.

Show evidence (3 references)

PMID:35390279 SUPPORT Human Clinical

Establishes biallelic PRDM13 mutation as the cause of this PCH-like phenotype.

PMID:35390279 SUPPORT Human Clinical

"Brain MRI and fetopathological examination revealed a PCH-like phenotype, associated with major hypoplasia of inferior olive nuclei and dysplasia of the dentate nucleus."

Sources the inferior olive and dentate findings named in this node's description.

PMID:35390279 SUPPORT Human Clinical

"Notably, histopathological examinations highlighted a sparse and disorganized Purkinje cell layer in the cerebellum."

Sources the Purkinje cell layer finding named in this node's description.

Presynaptic Active Zone Assembly Failure

PCLO encodes Piccolo, a scaffold protein of the presynaptic active zone. Biallelic nonsense PCLO variants underlie PCH3, historically described as cerebellar atrophy with progressive microcephaly, making PCH3 a synaptic rather than an RNA-processing or metabolic mechanism.

PCLO hgnc:13406

presynaptic active zone organization GO:1990709 ↓ DECREASED neurotransmitter secretion GO:0007269 ↓ DECREASED

Downstream

Impaired Cerebellar Development and Progressive Degeneration Loss of presynaptic active zone scaffolding converges on the shared pontocerebellar endpoint.

Show evidence (1 reference)

PMID:25832664 SUPPORT Human Clinical

"Here, we show that a homozygous, nonsense PCLO mutation underlies the autosomal recessive neurodegenerative disorder, PCH3."

Establishes biallelic PCLO loss of function as the cause of PCH3.

Impaired Cerebellar Development and Progressive Degeneration

Convergent downstream consequence of TSEN complex dysfunction, mitochondrial tRNA synthetase deficiency, and motor neuron degeneration. Pontocerebellar neurons fail to develop normally in utero (prenatal onset), followed by progressive postnatal degeneration. Neuropathology shows reduced cerebellar volume, simplified or absent foliation, and hypoplastic pons with loss of pontine nuclei. The cerebral cortex is relatively spared. MRI shows the characteristic dragonfly or butterfly sign of hypoplastic cerebellar hemispheres with preserved vermis in PCH2.

Downstream

Cerebellar Hypoplasia Cerebellar hypoplasia with prenatal onset and progressive postnatal atrophy is the cardinal structural consequence of the converged mechanism.

Hypoplasia of the Pons Loss of pontine nuclei and transverse fibres accompanies the cerebellar lesion in most subtypes.

Progressive Microcephaly Continuing postnatal degeneration produces head growth that falls progressively away from the normal range.

Severe Intellectual Disability Failure of pontocerebellar development and ongoing degeneration leave profound cognitive impairment.

Seizures Cortical and subcortical involvement accompanying the pontocerebellar lesion gives rise to seizures in a large fraction of patients.

Progressive Neurodegeneration and Poor Survival Degeneration continues after birth and determines the poor prognosis of the group.

Feeding Difficulties Bulbar dysfunction from the pontocerebellar lesion impairs sucking and swallowing from the neonatal period onward.

Show evidence (2 references)

PMID:20952379 SUPPORT Human Clinical

"The common characteristics are cerebellar hypoplasia with variable atrophy of the cerebellum and the ventral pons."

Confirms cerebellar and pontine hypoplasia as the universal neuropathological endpoint across PCH subtypes.

PMID:20952379 SUPPORT Human Clinical

"We found a strong correlation (P < 0.0005) between TSEN54 mutations and a dragonfly-like cerebellar pattern on magnetic resonance imaging, in which the cerebellar hemispheres are flat and severely reduced in size and the vermis is relatively spared."

Establishes the characteristic dragonfly MRI pattern as a radiological correlate of the cerebellar degeneration in TSEN54-related PCH.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

Digestive 1

Feeding Difficulties FREQUENT HP:0011968

Show evidence (1 reference)

PMID:22569581 SUPPORT Human Clinical

"The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."

Documents feeding difficulties as part of the PCH6 clinical spectrum.

Head and Neck 1

Progressive Microcephaly VERY_FREQUENT HP:0000253

Show evidence (2 references)

PMID:21749694 SUPPORT Human Clinical

"All subtypes share common characteristics, including hypoplasia/atrophy of cerebellum and pons, progressive microcephaly, and variable cerebral involvement."

Establishes progressive microcephaly as a common feature across PCH subtypes.

PMID:22569581 SUPPORT Human Clinical

"The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."

Documents progressive microcephaly in PCH6 (RARS2) patients on long-term follow-up.

Metabolism 1

Lactic Acidosis FREQUENT HP:0003128

Show evidence (1 reference)

PMID:22569581 SUPPORT Human Clinical

"Blood and CSF lactate was abnormally elevated in all five patients at early stages"

Supports elevated lactate as a frequent early biochemical feature in the original PCH6 cohort.

Musculoskeletal 1

Hypotonia VERY_FREQUENT HP:0001252

Show evidence (1 reference)

PMID:19646678 SUPPORT Human Clinical

"The spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of disorders characterized by degeneration and loss of anterior horn cells in the spinal cord, leading to muscle weakness and atrophy."

VRK1 loss-of-function causes SMA-PCH (PCH1A) with degeneration of anterior horn cells, producing hypotonia and muscle weakness as core features.

Nervous System 6

Cerebellar Hypoplasia VERY_FREQUENT HP:0001321

Show evidence (1 reference)

PMID:21749694 SUPPORT Human Clinical

"All subtypes share common characteristics, including hypoplasia/atrophy of cerebellum and pons, progressive microcephaly, and variable cerebral involvement."

Confirms cerebellar hypoplasia/atrophy as a shared characteristic of all PCH subtypes.

Hypoplasia of the Pons FREQUENT HP:0012110

Show evidence (1 reference)

PMID:18711368 SUPPORT Human Clinical

"Pontocerebellar hypoplasias (PCH) represent a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments."

Establishes pontine hypoplasia as part of the core neuropathological phenotype defining PCH.

Dyskinesia FREQUENT HP:0100660

Show evidence (1 reference)

PMID:20952379 SUPPORT Human Clinical

"Mutations in TSEN54 are clinically associated with dyskinesia and/or dystonia and variable degrees of spasticity, in some cases with pure generalized spasticity."

Directly links TSEN54 mutations (PCH2) to dyskinesia and dystonia as characteristic clinical features.

Seizures FREQUENT HP:0001250

Show evidence (2 references)

PMID:21749694 SUPPORT Human Clinical

"Patients have severe cognitive and motor handicaps and seizures are often reported."

Confirms seizures as a frequently reported feature across PCH subtypes.

PMID:22569581 SUPPORT Human Clinical

"All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures."

Establishes early-onset intractable epilepsy as a defining feature of PCH6 (RARS2 mutations).

Severe Intellectual Disability VERY_FREQUENT Profound intellectual disability HP:0002187

Show evidence (2 references)

PMID:18711368 SUPPORT Human Clinical

Establishes severe mental impairments as part of the defining phenotype of PCH.

PMID:22569581 SUPPORT Human Clinical

"The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."

Documents virtual absence of psychomotor development (equivalent to profound intellectual disability) in PCH6.

Progressive Neurodegeneration and Poor Survival FREQUENT HP:0002180

Course: PROGRESSIVE

Show evidence (2 references)

PMID:21749694 SUPPORT Human Clinical

"Treatment is only symptomatic and prognosis is poor, as most patients die during infancy or childhood."

Supports poor survival as a major prognostic feature of PCH.

PMID:23284067 SUPPORT Human Clinical

"EXOSC3 mutations account for 30%-40% of patients with PCH1 with variability in survival and clinical severity that is correlated with the genotype."

Clarifies that survival is subtype- and genotype-dependent, especially within PCH1B.

Respiratory 1

Respiratory Insufficiency FREQUENT HP:0002093

Show evidence (1 reference)

PMID:20952379 SUPPORT Human Clinical

"Nonsense or splice site mutations in TSEN54 are associated with a more severe phenotype of more perinatal symptoms, ventilator dependency and early death."

Documents respiratory insufficiency severe enough to require ventilator support in PCH4 patients with null TSEN54 alleles.

🧬

Genetic Associations

TSEN54 mutations (PCH2, PCH4) (Causative)

Gene: TSEN54 hgnc:27561

Show evidence (4 references)

PMID:18711368 SUPPORT Human Clinical

"In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex."

Establishes TSEN complex subunit mutations (predominantly TSEN54) as causative for PCH2 and PCH4.

PMID:20803644 SUPPORT Human Clinical

"This mutation results in an amino acid substitution of alanine for serine at codon 307 (A307S), and it has previously been described in a Northern European subset of patients with PCH2"

Sources the p.Ala307Ser founder allele and its Northern European ancestry association stated in these notes.

PMID:21368912 SUPPORT Human Clinical

"The PCH5 patient was found to be the result of compound heterozygosity for the common TSEN54 mutation (p.A307S) plus a novel splice site mutation."

Sources the PCH5 genotype named in these notes and the third TSEN54 subtype this record spans.

+ 1 more reference

VRK1 mutations (PCH1A) (Causative)

Gene: VRK1 hgnc:12718

Show evidence (1 reference)

PMID:19646678 SUPPORT Human Clinical

"identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"

First identification of VRK1 as the causative gene for PCH1A (SMA-PCH) in human patients.

RARS2 mutations (PCH6) (Causative)

Gene: RARS2 hgnc:21406

Show evidence (1 reference)

PMID:17847012 SUPPORT Human Clinical

"identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase"

First identification of RARS2 as the causative gene for PCH6 (mitochondrial aminoacyl-tRNA synthetase deficiency).

EXOSC3 mutations (PCH1B) (Causative)

Gene: EXOSC3 hgnc:17944

Show evidence (1 reference)

PMID:23284067 SUPPORT Human Clinical

"Biallelic mutations in EXOSC3 were detected in 10 of 27 families (37%)."

Establishes biallelic EXOSC3 variants as causative for a substantial subset of PCH1/PCH1B.

CLP1 mutations (PCH10) (Causative)

Gene: CLP1 hgnc:16999

Show evidence (1 reference)

PMID:24766809 SUPPORT Human Clinical

"Thus, we have identified a defined clinical syndrome with progressive central and peripheral nervous system defects in 11 affected children from five families, all of whom carry a homozygous CLP1 R140H mutation."

Establishes homozygous CLP1 R140H as causal for a PCH10-related central and peripheral nervous system disorder.

EXOSC8 mutations (PCH1C) (Causative)

Gene: EXOSC8 hgnc:17035

Show evidence (2 references)

PMID:33463720 SUPPORT BACKGROUND Human Clinical

Assigns biallelic EXOSC8 variants to PCH1C.

PMID:31768969 SUPPORT REVIEW SYNTHESIS Human Clinical

"mutations in the structural exosome genes EXOSC3 and EXOSC8 cause pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c), respectively, which are related autosomal recessive, neurodegenerative diseases."

Confirms EXOSC8 as the PCH1C gene and the autosomal recessive mode.

EXOSC9 mutations (PCH1D) (Causative)

Gene: EXOSC9 hgnc:9137

Show evidence (2 references)

PMID:33463720 SUPPORT BACKGROUND Human Clinical

Assigns biallelic EXOSC9 variants to PCH1D.

PMID:31768969 SUPPORT REVIEW SYNTHESIS Human Clinical

"mutations in the structural exosome gene EXOSC9 cause a PCH-like disease with cerebellar atrophy and spinal motor neuronopathy."

Describes the EXOSC9 phenotype recorded in this entry.

SLC25A46 mutations (PCH1E) (Causative)

Gene: SLC25A46 hgnc:25198

Show evidence (2 references)

PMID:27543974 SUPPORT Human Clinical

Reports the biallelic SLC25A46 lesions underlying lethal congenital pontocerebellar hypoplasia.

PMID:40428407 SUPPORT REVIEW SYNTHESIS Human Clinical

Places SLC25A46 among the recessive PCH1 genes.

TSEN2 mutations (PCH2B) (Causative)

Gene: TSEN2 hgnc:28422

Show evidence (2 references)

PMID:41621844 SUPPORT REVIEW SYNTHESIS Human Clinical

"Literature review has identified six PCH2B patients with missense, nonsense, frameshift, and splice site variants of the TSEN2 gene."

Assigns TSEN2 variants to PCH2B and indicates how few cases are reported.

PMID:20803644 SUPPORT BACKGROUND Human Clinical

"Most patients with PCH2 have mutations in TSEN54, with occasional mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA splicing endonuclease."

Supports TSEN2 as an infrequent PCH2 gene relative to TSEN54.

TSEN34 mutations (PCH2C) (Causative)

Gene: TSEN34 hgnc:15506

Show evidence (2 references)

PMID:20803644 SUPPORT BACKGROUND Human Clinical

"Most patients with PCH2 have mutations in TSEN54, with occasional mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA splicing endonuclease."

Assigns TSEN34 to PCH2 as an infrequent cause.

PMID:18711368 SUPPORT Human Clinical

"In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex."

Original report identifying mutations in three TSEN subunits, including TSEN34, in PCH2 and PCH4.

TSEN15 mutations (PCH2F) (Causative)

Gene: TSEN15 hgnc:16791

Show evidence (1 reference)

PMID:27392077 SUPPORT Human Clinical

"Here, we report three homozygous TSEN15 variants that cause a milder version of PCH2."

Establishes biallelic TSEN15 variants as a cause of a milder PCH2 phenotype.

PCLO mutations (PCH3) (Causative)

Gene: PCLO hgnc:13406

Show evidence (1 reference)

PMID:25832664 SUPPORT Human Clinical

"Here, we show that a homozygous, nonsense PCLO mutation underlies the autosomal recessive neurodegenerative disorder, PCH3."

Establishes biallelic PCLO loss of function as the cause of PCH3.

TOE1 mutations (PCH7) (Causative)

Gene: TOE1 hgnc:15954

Show evidence (2 references)

PMID:38605133 SUPPORT BACKGROUND Human Clinical

"Biallelic TOE1 variants can cause pontocerebellar hypoplasia type 7 (PCH7), a condition characterized by pontocerebellar hypoplasia with genital abnormality."

States the TOE1-PCH7 assignment and the distinguishing genital feature.

PMID:42178111 SUPPORT In Vitro

"We performed characterization of the thermal stability and activity of eleven PCH-linked TOE1 variants and found that eight variants have significant reduced protein thermal stability and that all but two variants impair TOE1's ribonuclease activity, particularly its exonuclease activity."

Shows that PCH-linked TOE1 variants reduce the protein's ribonuclease activity, supporting loss of function.

CHMP1A mutations (PCH8) (Causative)

Gene: CHMP1A hgnc:8740

Show evidence (1 reference)

PMID:23023333 SUPPORT Human Clinical

"Here, we show that loss-of-function mutations in human CHMP1A cause reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral cortical size (microcephaly)."

Establishes biallelic CHMP1A loss of function as a cause of pontocerebellar hypoplasia with microcephaly.

AMPD2 mutations (PCH9) (Causative)

Gene: AMPD2 hgnc:469 gene page

Show evidence (2 references)

PMID:29463858 SUPPORT Human Clinical

"We identified homozygous or compound heterozygous AMPD2 variants in eight PCH-affected individuals from six families."

Establishes biallelic AMPD2 variants as a cause of pontocerebellar hypoplasia.

PMID:29463858 SUPPORT Human Clinical

Supports the isoform-dependent split between AMPD2-related SPG63 and PCH9.

TBC1D23 mutations (PCH11) (Causative)

Gene: TBC1D23 hgnc:25622

Show evidence (2 references)

PMID:40581672 SUPPORT BACKGROUND Human Clinical

"Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive disorder caused by variants in TBC1D23."

States the TBC1D23-PCH11 gene-disease assignment.

PMID:38413626 SUPPORT In Vitro

"TBC1D23, a Golgi-localized protein that is frequently mutated in the neurodevelopment disorder pontocerebellar hypoplasia (PCH), is specifically required for the LKB1 signaling at the Golgi."

Sources the Golgi localisation and LKB1 signalling role described here.

COASY mutations (PCH12) (Causative)

Gene: COASY hgnc:29932

Show evidence (2 references)

PMID:35499143 SUPPORT BACKGROUND Human Clinical

"Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal neurodegenerative genetic disorder caused by biallelic mutations in the COASY gene."

Establishes biallelic COASY mutation as the cause of PCH12.

PMID:39301217 SUPPORT BACKGROUND Human Clinical

Supports the allele-severity split between PCH12 and COASY protein-associated neurodegeneration.

PPIL1 mutations (PCH14) (Causative)

Gene: PPIL1 hgnc:9260

Show evidence (2 references)

PMID:33220177 SUPPORT Human Clinical

"Patients harbored biallelic mutations in genes encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17 (PRP17)."

Establishes biallelic PPIL1 variants as a cause of pontocerebellar hypoplasia with microcephaly.

PMID:37190898 SUPPORT BACKGROUND Human Clinical

"Biallelic variants in PPIL1 have been recently found to cause a very rare type of pontocerebellar hypoplasia and congenital microcephaly in which simplified gyral pattern was not observed in all of the patients."

Independent series confirming the PPIL1 gene-disease assignment and describing its imaging variability.

MINPP1 mutations (PCH16) (Causative)

Gene: MINPP1 hgnc:7102

Show evidence (2 references)

PMID:40508022 SUPPORT BACKGROUND Human Clinical

"Multiple subtypes of PCH have been identified, among which the rare subtype PCH type 16 is caused by MINPP1 genetic variants."

Establishes MINPP1 as the PCH16 gene.

PMID:33257696 SUPPORT In Vitro

Supports inositol hexakisphosphate accumulation as the proposed consequence of MINPP1 loss.

PRDM13 mutations (PCH17) (Causative)

Gene: PRDM13 hgnc:13998 gene page

Show evidence (2 references)

PMID:35390279 SUPPORT Human Clinical

Establishes biallelic PRDM13 mutation as the cause of this PCH-like perinatal phenotype.

PMID:35390279 SUPPORT Human Clinical

"snRNA-seq data mining and in situ hybridization in humans show that PRDM13 is expressed at early stages in the progenitors of the cerebellar ventricular zone, which gives rise to cerebellar GABAergic neurons, including Purkinje cells."

Sources the cerebellar ventricular zone progenitor expression described here.

💊

Medical Actions

Symptomatic and Supportive Care

Action: supportive care Ontology label: Supportive Care NCIT:C15747

No disease-modifying therapy exists for any PCH subtype. Management is supportive: nutritional support via nasogastric tube or gastrostomy, respiratory support (including mechanical ventilation for severe cases), physiotherapy to manage spasticity and contractures, and palliative care. Genetic counselling for families is essential. One subtype-specific preventive measure is documented: children with TSEN54-related PCH2 carry an increased risk of rhabdomyolysis during severe infections, and GeneReviews recommends adequate hydration through prolonged high fever to reduce it.

Show evidence (3 references)

PMID:21749694 SUPPORT Human Clinical

"Treatment is only symptomatic and prognosis is poor, as most patients die during infancy or childhood."

Confirms that only symptomatic treatment is available and prognosis is poor across PCH subtypes.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"Children with PCH2 have generalized clonus, uncoordinated sucking and swallowing, impaired cognitive development, lack of voluntary motor development, cortical blindness, and an increased risk for rhabdomyolysis during severe infections."

Names the rhabdomyolysis risk during febrile illness that the hydration measure below is directed at.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"Adequate hydration during prolonged periods of high fever may help avoid rhabdomyolysis."

The one specific preventive measure GeneReviews gives for TSEN54-related PCH, beyond general symptomatic care.

Feeding and Swallowing Support

Action: feeding therapy Ontology label: Swallowing Therapy NCIT:C156237

Feeding therapy, aspiration-risk assessment, and enteral nutrition by nasogastric or gastrostomy tube are important for affected infants with dysphagia, hypotonia, failure to thrive, or severe neurodevelopmental impairment. This is supportive care and not disease-modifying treatment.

Show evidence (2 references)

PMID:22569581 SUPPORT Human Clinical

"The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."

Supports feeding support as a clinically relevant management domain, especially in severe PCH6.

PMID:21749694 SUPPORT Human Clinical

"Treatment is only symptomatic and prognosis is poor, as most patients die during infancy or childhood."

Supports supportive management for severe PCH manifestations.

Respiratory Support and Palliative Planning

Action: palliative care Ontology label: Palliative Therapy NCIT:C15292

Respiratory monitoring, noninvasive or invasive ventilation when consistent with goals of care, and early palliative-care planning are relevant for severe PCH1A/PCH1B, PCH4, and other forms with hypoventilation, ventilator dependence, or life-limiting neurologic disease.

Show evidence (2 references)

PMID:20952379 SUPPORT Human Clinical

"Nonsense or splice site mutations in TSEN54 are associated with a more severe phenotype of more perinatal symptoms, ventilator dependency and early death."

Supports respiratory support and palliative planning for severe TSEN54-related PCH4.

PMID:23284067 SUPPORT Human Clinical

"Major clinical features previously reported in PCH1, including intrauterine abnormalities, postnatal hypoventilation and feeding difficulties, joint contractures, and neonatal death, were rarely observed in mutation-positive infants but were typical among the mutation-negative subjects."

Supports respiratory and end-of-life planning for severe PCH1 presentations.

Physical Therapy and Movement-Disorder Care

Action: physical therapy Ontology label: Physical Therapy NCIT:C15302

Platform: Behavioral / lifestyle

Physical therapy, positioning, contracture prevention, and symptom-directed movement-disorder management address hypotonia, spasticity, dystonia, dyskinesia, and progressive motor disability. These interventions are supportive and should be individualized by subtype and severity.

Show evidence (3 references)

PMID:20952379 SUPPORT Human Clinical

"Mutations in TSEN54 are clinically associated with dyskinesia and/or dystonia and variable degrees of spasticity, in some cases with pure generalized spasticity."

Supports movement-disorder and spasticity-oriented supportive management in TSEN54-related PCH.

PMID:21749694 SUPPORT Human Clinical

"Patients have severe cognitive and motor handicaps and seizures are often reported."

Supports motor-disability-directed supportive therapy across PCH subtypes.

PMID:25144110 SUPPORT REVIEW SYNTHESIS Human Clinical

"Contractures and scoliosis are managed by passive or active movement and bracing as needed."

Names the specific musculoskeletal measures GeneReviews recommends, which this treatment covers.

Antiepileptic Pharmacotherapy

Action: Pharmacotherapy NCIT:C15986

Anticonvulsant medications for management of epileptic seizures in PCH2 and PCH6. No specific anticonvulsant is preferred; polytherapy is often required for refractory epilepsy in PCH6.

Show evidence (1 reference)

PMID:22569581 SUPPORT Human Clinical

"All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures."

Intractable seizures in PCH6 require anticonvulsant pharmacotherapy, consistent with antiepileptic drug use as a standard management approach.

Genetic Counseling

Action: Genetic Counseling NCIT:C15240

Genetic counseling should address autosomal-recessive inheritance, recurrence risk, carrier testing, molecular confirmation of the familial subtype, and reproductive options including prenatal and preimplantation genetic testing when familial variants are known.

Show evidence (1 reference)

PMID:21749694 SUPPORT Human Clinical

"The genetic basis of different subtypes has been elucidated, which makes prenatal testing possible in families with mutations."

Supports counseling around molecular subtype, recurrence risk, and prenatal testing options.

🔬

Diagnosis

Neuroimaging and Clinical Subtype Assessment

Brain MRI is central to recognizing PCH, documenting cerebellar and ventral pontine hypoplasia, and distinguishing subtype patterns such as the TSEN54-related dragonfly-like cerebellar pattern. Serial clinical and imaging data help separate prenatal maldevelopment from progressive postnatal atrophy.

MRI of the brain NCIT:C16809

Show evidence (2 references)

DOI:10.1093/braincomms/fcaf298 SUPPORT Human Clinical

"It can be diagnosed prenatally or postnatally with a combination of clinical, neuroimaging and genetic data obtained over time."

Supports integrated clinical and neuroimaging assessment as part of PCH diagnosis.

PMID:20952379 SUPPORT Human Clinical

Supports brain MRI as a subtype-informative diagnostic procedure, especially for TSEN54-related PCH2/PCH4.

Molecular Genetic Testing

Multigene panel, exome, or genome testing should evaluate the broad PCH gene spectrum and classify subtype-specific causes, including TSEN54/TSEN genes, RARS2, VRK1, EXOSC3, and CLP1. Biallelic variant interpretation is essential for subtype assignment, recurrence-risk counseling, and prenatal options.

molecular genetic testing NCIT:C19770

Show evidence (4 references)

DOI:10.1093/braincomms/fcaf298 SUPPORT Human Clinical

"The diagnosis conveys significant implications for the affected individual and their families and requires a combination of clinical, neuroradiographic, and genetic testing to best inform type/subtype categorization of pontocerebellar hypoplasia."

Supports genetic testing as a diagnostic requirement for PCH type/subtype categorization.

PMID:20301773 SUPPORT REVIEW SYNTHESIS Human Clinical

"is confirmed by the presence of biallelic TSEN54 pathogenic variants."

GeneReviews states that biallelic variant detection is what confirms the diagnosis in the TSEN54 subtypes.

PMID:25144110 SUPPORT REVIEW SYNTHESIS Human Clinical

"is confirmed by the presence of biallelic EXOSC3 pathogenic variants identified by molecular genetic testing."

Same confirmation requirement stated for the EXOSC3 subtype, showing the rule is not TSEN54-specific.

+ 1 more reference

Neuromuscular Electrophysiology for PCH1 and PCH10 Presentations

Electromyography and nerve-conduction studies are appropriate when PCH presents with spinal muscular atrophy-like weakness, anterior horn cell involvement, or peripheral neuropathy, helping distinguish PCH1 and PCH10 patterns from primarily central PCH presentations.

nerve conduction study NCIT:C88502

Show evidence (2 references)

PMID:19646678 SUPPORT Human Clinical

Supports neuromuscular evaluation in PCH1A/SMA-PCH presentations with anterior horn cell involvement.

PMID:24766809 SUPPORT Human Clinical

"Electrophysiological studies revealed objective evidence for marked axonal sensorimotor neuropathies (Figure 2 and Table S1)."

Supports nerve-conduction/electrophysiologic evaluation in CLP1-related PCH10.

Prenatal and Familial Testing

Once familial pathogenic variants are known, prenatal testing or preimplantation genetic testing can be considered for future pregnancies in affected families, together with carrier testing and counseling for autosomal-recessive recurrence risk.

chorionic villus sampling NCIT:C18020

Show evidence (1 reference)

PMID:21749694 SUPPORT Human Clinical

"The genetic basis of different subtypes has been elucidated, which makes prenatal testing possible in families with mutations."

Supports prenatal molecular testing once disease-causing familial mutations have been identified.

🔬

Clinical Trials

NCT04378075 PHASE_II TERMINATED

Randomized, double-blind, placebo-controlled Phase 2/3 trial evaluating vatiquinone (PTC743/EPI-743) for mitochondrial disease with refractory epilepsy. Pontocerebellar Hypoplasia Type 6 (RARS2) was listed among the eligible conditions in the ClinicalTrials.gov record, making the trial relevant to the curated PCH6 subtype.

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

clinicaltrials:NCT04378075 SUPPORT

"This is a parallel-arm, double-blind, placebo-controlled study with a screening phase that includes a 28-day run-in phase to establish baseline seizure frequency, followed by a 24-week, randomized, placebo-controlled phase."

The fetched ClinicalTrials.gov cache supports the trial design and seizure endpoint context for vatiquinone in mitochondrial disease with refractory epilepsy; the public record lists PCH6 among eligible mitochondrial disease conditions.

🧫

Experimental Models

PCH2A Patient-Derived Regional Neural Organoids ORGANOID

Human induced pluripotent stem cell lines from individuals homozygous for the TSEN54 p.Ala307Ser founder variant were differentiated into cerebellar and neocortical organoids. The model recapitulates the region-specific growth deficit of PCH2A and supports altered progenitor proliferation kinetics as an early neurodevelopmental mechanism.

Organism

human NCBITaxon:9606

Cell source

patient-derived induced pluripotent stem cells

Culture

regionalized cerebellar and neocortical organoids

Pathograph links

TSEN/CLP1 Dysfunction and Impaired Pre-tRNA Splicing Recapitulates TSEN54-related, brain-region-specific organoid growth reduction and altered neural progenitor proliferation.

Show evidence (1 reference)

DOI:10.1242/dmm.050740 SUPPORT In Vitro

"PCH2a cerebellar organoids were reduced in size compared to controls starting early in differentiation."

Shows the organoid model reproduces early cerebellar growth reduction.

Show evidence (1 reference)

DOI:10.1242/dmm.050740 SUPPORT In Vitro

"we developed human models of PCH2a using regionalized neural organoids."

Establishes a human iPSC-derived organoid model system for PCH2A.

{ }

Source YAML

click to show

name: Pontocerebellar Hypoplasia
creation_date: "2026-04-25T00:00:00Z"
category: Mendelian
description: >
  Pontocerebellar hypoplasia (PCH) is a clinically and genetically heterogeneous group of
  autosomal recessive neurodegenerative disorders characterized by prenatal-onset hypoplasia and
  progressive atrophy of the cerebellum and ventral pons, severe intellectual disability,
  limited motor development, and variable extra-neural features. PCH is divided into numbered
  subtypes, each defined by its causal gene; most of the genes function in RNA processing or
  translation, the tRNA splicing endonuclease (TSEN) complex and the RNA exosome being the
  largest groups among the subtypes curated here, and PCH2 (TSEN54) is the most common form.
  Several subtypes fall outside that theme entirely: PCH3 is a presynaptic active zone defect
  (PCLO), PCH8 an ESCRT-III defect in which cerebellar progenitors fail to proliferate (CHMP1A),
  PCH11 a Golgi retrograde-trafficking defect (TBC1D23), PCH9, PCH12 and PCH16 metabolic enzyme
  deficiencies (AMPD2, COASY, MINPP1), PCH1E a mitochondrial dynamics defect (SLC25A46), and
  PCH17 a failure of cerebellar GABAergic neuron specification (PRDM13). No disease-modifying
  therapy exists and management remains supportive.
disease_term:
  preferred_term: pontocerebellar hypoplasia
  term:
    id: MONDO:0020135
    label: pontocerebellar hypoplasia
parents:
- Neurodegenerative Disease
- Cerebellar Hypoplasia
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >
    All major PCH forms show autosomal recessive inheritance. Most cases result from
    homozygous founder mutations (e.g., TSEN54 A307S in PCH2) or compound heterozygous
    loss-of-function alleles.
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pontocerebellar Hypoplasia (PCH) is group of very rare, inherited progressive neurodegenerative disorders with prenatal onset."
    explanation: Review confirming PCH as an inherited neurodegenerative group, consistent with autosomal recessive inheritance established across all subtypes.
  - reference: PMID:20301773
    reference_title: TSEN54 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      TSEN54-PCH is inherited in an autosomal recessive manner.
    explanation: >-
      GeneReviews states the recessive inheritance of the largest PCH subtype
      group directly.
  - reference: PMID:20301773
    reference_title: TSEN54 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      If both parents are known to be heterozygous for a TSEN54 pathogenic
      variant, each sib of an affected individual has at conception a 25% chance
      of inheriting both pathogenic variants and being affected, a 50% chance of
      inheriting one pathogenic variant and being an unaffected carrier, and a
      25% chance of inheriting both normal alleles.
    explanation: >-
      Gives the recurrence risks that follow from the recessive mode recorded
      here.

has_subtypes:
- name: PCH1A
  display_name: PCH Type 1A (VRK1)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 1A
    term:
      id: MONDO:0011866
      label: pontocerebellar hypoplasia type 1A
  description: >
    Pontocerebellar hypoplasia type 1A caused by biallelic VRK1 mutations. Characterized
    by cerebellar and pontine hypoplasia combined with anterior horn cell degeneration
    (resembling spinal muscular atrophy), severe hypotonia, and respiratory insufficiency.
    MONDO:0011866.
  genes:
  - preferred_term: VRK1
    term:
      id: hgnc:12718
      label: VRK1
  evidence:
  - reference: PMID:19646678
    reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"
    explanation: Establishes VRK1 as the causal gene for the SMA-PCH/PCH1A subtype.
- name: PCH1B
  display_name: PCH Type 1B (EXOSC3)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 1B
    term:
      id: MONDO:0013853
      label: pontocerebellar hypoplasia type 1B
  description: >
    Pontocerebellar hypoplasia type 1B caused by biallelic EXOSC3 mutations.
    This PCH1 subtype combines pontocerebellar hypoplasia with spinal muscular
    atrophy-like weakness, profound developmental impairment, and variable
    survival.
  genes:
  - preferred_term: EXOSC3
    term:
      id: hgnc:17944
      label: EXOSC3
  evidence:
  - reference: PMID:23284067
    reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "EXOSC3 mutations account for 30%-40% of patients with PCH1 with variability in survival and clinical severity that is correlated with the genotype."
    explanation: Establishes EXOSC3 as a major cause of PCH1, corresponding to the PCH1B subtype.
  - reference: PMID:25144110
    reference_title: EXOSC3 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      EXOSC3 pontocerebellar hypoplasia (EXOSC3-PCH) is characterized by
      abnormalities in the posterior fossa and degeneration of the anterior horn
      cells.
    explanation: >-
      GeneReviews chapter for the EXOSC3 form of PCH, confirming the anterior
      horn cell involvement that defines the PCH1 group.
- name: PCH2
  display_name: PCH Type 2 (TSEN54)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 2
    term:
      id: MONDO:0016759
      label: pontocerebellar hypoplasia type 2
  description: >
    The most common form of PCH, caused by TSEN54 mutations (most commonly the A307S
    founder allele). Characterized by progressive microcephaly, dyskinesia, and seizures
    with relative preservation of the brainstem. This row is the PCH2 group term;
    the gene-specific forms are enumerated separately as PCH2A (TSEN54), PCH2B
    (TSEN2), PCH2C (TSEN34) and PCH2F (TSEN15). PCH2D is caused by SEPSECS and
    PCH2E by VPS53; neither is curated on this entry, and VPS53-related PCH2E has
    its own dismech entry. MONDO:0016759.
  genes:
  - preferred_term: TSEN54
    term:
      id: hgnc:27561
      label: TSEN54
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mutations in the transfer RNA splicing endonuclease subunit genes (TSEN54, TSEN2, TSEN34) were found to be associated with pontocerebellar hypoplasia types 2 and 4."
    explanation: Supports TSEN-complex mutation association with PCH2 and grounds TSEN54 as the most common PCH2 gene in this entry.
- name: PCH4
  display_name: PCH Type 4 (TSEN54, severe)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 4
    term:
      id: MONDO:0009166
      label: pontocerebellar hypoplasia type 4
  description: >
    Severe form caused by biallelic TSEN54 null or severe compound heterozygous alleles.
    Neonatal lethal with generalized clonus, olivopontocerebellar hypoplasia, and
    respiratory failure. MONDO:0009166.
  genes:
  - preferred_term: TSEN54
    term:
      id: hgnc:27561
      label: TSEN54
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nonsense or splice site mutations in TSEN54 are associated with a more severe phenotype of more perinatal symptoms, ventilator dependency and early death."
    explanation: Supports the severe neonatal/early lethal PCH4 phenotype associated with null or splice-site TSEN54 alleles.
- name: PCH6
  display_name: PCH Type 6 (RARS2)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 6
    term:
      id: MONDO:0012683
      label: pontocerebellar hypoplasia type 6
  description: >
    Caused by mutations in RARS2, encoding mitochondrial arginyl-tRNA synthetase.
    Features cerebellar and pontine hypoplasia, severe intellectual disability,
    epilepsy, and elevated CSF lactate reflecting mitochondrial dysfunction. MONDO:0012683.
  genes:
  - preferred_term: RARS2
    term:
      id: hgnc:21406
      label: RARS2
  evidence:
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Recessive mutations in the mitochondrial arginyl-transfer RNA synthetase (RARS2) gene have been associated with early onset encephalopathy with signs of oxidative phosphorylation defects classified
      as pontocerebellar hypoplasia 6."
    explanation: Establishes RARS2 mutations as the molecular basis of PCH6.
- name: PCH10
  display_name: PCH Type 10 (CLP1)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 10
    term:
      id: MONDO:0014349
      label: pontocerebellar hypoplasia type 10
  description: >
    Pontocerebellar hypoplasia type 10 caused by biallelic CLP1 mutations. CLP1
    interacts with the TSEN complex in tRNA splicing, and affected individuals
    can have severe motor-sensory defects, microcephaly, seizures, cortical
    dysgenesis, and peripheral neuropathy.
  genes:
  - preferred_term: CLP1
    term:
      id: hgnc:16999
      label: CLP1
  evidence:
  - reference: PMID:24766809
    reference_title: "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A parallel study (Schaffer et al. this issue) reported CLP1 mutation in association with a clinical phenotype of pontocerebellar hypoplasia; they also report a R140H founder mutation."
    explanation: Supports CLP1 mutation as a pontocerebellar hypoplasia subtype mechanism, corresponding to PCH10.
- name: PCH1C
  display_name: PCH Type 1C (EXOSC8)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 1C
    term:
      id: MONDO:0014485
      label: pontocerebellar hypoplasia, type 1C
  description: >-
    Pontocerebellar hypoplasia type 1C is the EXOSC8-associated form of PCH1.
    EXOSC8 encodes a structural subunit of the RNA exosome, the same complex
    whose EXOSC3 subunit underlies PCH1B, so PCH1C shares the PCH1 pattern of pontocerebellar hypoplasia with anterior horn cell
    degeneration and spinal muscular atrophy-like weakness.
  genes:
  - preferred_term: EXOSC8
    term:
      id: hgnc:17035
      label: EXOSC8
  evidence:
  - reference: PMID:33463720
    reference_title: "Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Bi-allelic variants in exosome subunits EXOSC3, EXOSC8 and EXOSC9 have
      been reported to cause pontocerebellar hypoplasia type 1B, type 1C and
      type 1D, respectively, while those in EXOSC2 cause short stature, hearing
      loss, retinitis pigmentosa and distinctive facies.
    explanation: >-
      States that biallelic EXOSC8 variants cause pontocerebellar hypoplasia
      type 1C, the gene-disease assignment this subtype row records.
  - reference: PMID:40428407
    reference_title: "Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      PCH1 is defined as PCH variant associated with anterior horn degeneration
      in the spinal cord with muscle weakness and hypotonia, and is associated
      with recessive variants in genes VRK1, EXOSC3, EXOSC8, EXOSC9 and
      SLC25A46.
    explanation: >-
      Places EXOSC8 among the recessive PCH1 genes and states the anterior horn
      cell involvement that defines the PCH1 group.
- name: PCH1D
  display_name: PCH Type 1D (EXOSC9)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 1D
    term:
      id: MONDO:0054844
      label: pontocerebellar hypoplasia, type 1D
  description: >-
    Pontocerebellar hypoplasia type 1D is the EXOSC9-associated form of PCH1.
    EXOSC9 is a third structural RNA exosome subunit in which biallelic variants
    produce cerebellar atrophy together with spinal motor neuronopathy, the PCH1
    phenotype pattern.
  genes:
  - preferred_term: EXOSC9
    term:
      id: hgnc:9137
      label: EXOSC9
  evidence:
  - reference: PMID:33463720
    reference_title: "Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Bi-allelic variants in exosome subunits EXOSC3, EXOSC8 and EXOSC9 have
      been reported to cause pontocerebellar hypoplasia type 1B, type 1C and
      type 1D, respectively, while those in EXOSC2 cause short stature, hearing
      loss, retinitis pigmentosa and distinctive facies.
    explanation: >-
      States that biallelic EXOSC9 variants cause pontocerebellar hypoplasia
      type 1D.
  - reference: PMID:31768969
    reference_title: "The RNA Exosome and Human Disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      mutations in the structural exosome gene EXOSC9 cause a PCH-like disease
      with cerebellar atrophy and spinal motor neuronopathy.
    explanation: >-
      Describes the EXOSC9 phenotype as cerebellar atrophy with spinal motor
      neuronopathy, the clinical content of this row.
- name: PCH1E
  display_name: PCH Type 1E (SLC25A46)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 1E
    term:
      id: MONDO:0030260
      label: pontocerebellar hypoplasia, type 1E
  description: >-
    Pontocerebellar hypoplasia type 1E is the SLC25A46-associated form of PCH1.
    SLC25A46 encodes a mitochondrial outer-membrane protein of the fission and
    fusion machinery rather than an RNA-processing factor, so PCH1E reaches the
    PCH1 phenotype by a mechanism distinct from the RNA exosome subtypes. Loss
    of function was first reported in neonatally lethal pontocerebellar
    hypoplasia with apnoea; milder SLC25A46 alleles cause optic atrophy and
    peripheral neuropathy.
  genes:
  - preferred_term: SLC25A46
    term:
      id: hgnc:25198
      label: SLC25A46
  evidence:
  - reference: PMID:27543974
    reference_title: "Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In siblings from two unrelated families who died soon after birth with a
      profound neurodevelopmental disorder characterized by pontocerebellar
      hypoplasia and apnoea, we discovered a missense mutation and an exonic
      deletion in the SLC25A46 gene encoding a mitochondrial protein recently
      implicated in optic atrophy spectrum disorder.
    explanation: >-
      Reports the biallelic SLC25A46 lesions in lethal congenital
      pontocerebellar hypoplasia that define this subtype.
  - reference: PMID:40428407
    reference_title: "Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      PCH1 is defined as PCH variant associated with anterior horn degeneration
      in the spinal cord with muscle weakness and hypotonia, and is associated
      with recessive variants in genes VRK1, EXOSC3, EXOSC8, EXOSC9 and
      SLC25A46.
    explanation: >-
      Places SLC25A46 among the recessive PCH1 genes.
- name: PCH2A
  display_name: PCH Type 2A (TSEN54)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 2A
    term:
      id: MONDO:0010190
      label: pontocerebellar hypoplasia type 2A
  description: >-
    Pontocerebellar hypoplasia type 2A is the TSEN54-associated form of PCH2,
    which is the most frequently reported and best studied PCH subtype. It sits
    alongside PCH4 and PCH5 as one of three TSEN54 phenotypes that differ mainly
    in life expectancy. Children with PCH2 carry an increased risk of
    rhabdomyolysis during severe infections, which is the one point in PCH
    management where a specific preventive measure applies.
  genes:
  - preferred_term: TSEN54
    term:
      id: hgnc:27561
      label: TSEN54
  evidence:
  - reference: PMID:20301773
    reference_title: "TSEN54 Pontocerebellar Hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH
      phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and
      neurologic findings.
    explanation: >-
      GeneReviews groups PCH2, PCH4 and PCH5 as the three TSEN54 phenotypes,
      which is the gene assignment this row records.
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      PCH type 2 (PCH2, ORPHA2524, MIM 277470, 612389, 612390) is the most
      frequently reported and therefore the best studied subtype
    explanation: >-
      Sources the statement that PCH2 is the most frequently reported and best
      studied subtype.
- name: PCH2B
  display_name: PCH Type 2B (TSEN2)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 2B
    term:
      id: MONDO:0012890
      label: pontocerebellar hypoplasia type 2B
  description: >-
    Pontocerebellar hypoplasia type 2B is the TSEN2-associated form of PCH2.
    TSEN2 encodes a catalytic subunit of the same tRNA splicing endonuclease
    complex as TSEN54, and PCH2B is far rarer than the TSEN54 form.
  genes:
  - preferred_term: TSEN2
    term:
      id: hgnc:28422
      label: TSEN2
  evidence:
  - reference: PMID:41621844
    reference_title: "[Pontocerebellar hypoplasia type 2B due to compound heterozygous variants of TSEN2 gene: A case report and literature review]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Literature review has identified six PCH2B patients with missense,
      nonsense, frameshift, and splice site variants of the TSEN2 gene.
    explanation: >-
      Assigns TSEN2 variants to PCH2B and indicates how few cases have been
      reported.
  - reference: PMID:20803644
    reference_title: "Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Most patients with PCH2 have mutations in TSEN54, with occasional
      mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA
      splicing endonuclease.
    explanation: >-
      Supports TSEN2 as an infrequent PCH2 gene relative to TSEN54.
- name: PCH2C
  display_name: PCH Type 2C (TSEN34)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 2C
    term:
      id: MONDO:0012891
      label: pontocerebellar hypoplasia type 2C
  description: >-
    Pontocerebellar hypoplasia type 2C is the TSEN34-associated form of PCH2.
    TSEN34 encodes the second catalytic subunit of the tRNA splicing
    endonuclease complex; like TSEN2, it accounts for only occasional PCH2
    cases.
  genes:
  - preferred_term: TSEN34
    term:
      id: hgnc:15506
      label: TSEN34
  evidence:
  - reference: PMID:20803644
    reference_title: "Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Most patients with PCH2 have mutations in TSEN54, with occasional
      mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA
      splicing endonuclease.
    explanation: >-
      Assigns TSEN34 to PCH2 as an infrequent cause, the gene-disease claim
      behind this row.
- name: PCH2F
  display_name: PCH Type 2F (TSEN15)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 2F
    term:
      id: MONDO:0014874
      label: pontocerebellar hypoplasia, type 2F
  description: >-
    Pontocerebellar hypoplasia type 2F is the TSEN15-associated form of PCH2.
    TSEN15 is the fourth subunit of the tRNA splicing endonuclease complex, and
    the reported TSEN15 phenotype is milder than the TSEN54 form of PCH2.
  genes:
  - preferred_term: TSEN15
    term:
      id: hgnc:16791
      label: TSEN15
  evidence:
  - reference: PMID:27392077
    reference_title: "Autosomal-Recessive Mutations in the tRNA Splicing Endonuclease Subunit TSEN15 Cause Pontocerebellar Hypoplasia and Progressive Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report three homozygous TSEN15 variants that cause a milder
      version of PCH2.
    explanation: >-
      Reports the biallelic TSEN15 variants that define this PCH2 subtype and
      its relatively milder course.
- name: PCH3
  display_name: PCH Type 3 (PCLO)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 3
    term:
      id: MONDO:0011948
      label: pontocerebellar hypoplasia type 3
  description: >-
    Pontocerebellar hypoplasia type 3, historically called cerebellar atrophy
    with progressive microcephaly, is caused by biallelic loss of PCLO. PCLO
    encodes Piccolo, a presynaptic active zone scaffold protein, so PCH3 is a
    synaptic rather than an RNA-processing mechanism.
  genes:
  - preferred_term: PCLO
    term:
      id: hgnc:13406
      label: PCLO
  evidence:
  - reference: PMID:25832664
    reference_title: "Loss of PCLO function underlies pontocerebellar hypoplasia type III."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we show that a homozygous, nonsense PCLO mutation underlies the
      autosomal recessive neurodegenerative disorder, PCH3.
    explanation: >-
      Establishes biallelic PCLO loss of function as the cause of PCH3.
- name: PCH5
  display_name: PCH Type 5 (TSEN54, fetal onset)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 5
    term:
      id: MONDO:0012438
      label: pontocerebellar hypoplasia type 5
  description: >-
    Pontocerebellar hypoplasia type 5 is a fetal-onset TSEN54 phenotype that
    overlaps PCH4 clinically and genotypically, with seizure-like activity in
    utero and early postnatal death. It is one of the three TSEN54 phenotypes
    recognised in GeneReviews and has been described in a single family.
  genes:
  - preferred_term: TSEN54
    term:
      id: hgnc:27561
      label: TSEN54
  evidence:
  - reference: PMID:21368912
    reference_title: "TSEN54 mutations cause pontocerebellar hypoplasia type 5."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The PCH5 patient was found to be the result of compound heterozygosity for
      the common TSEN54 mutation (p.A307S) plus a novel splice site mutation.
    explanation: >-
      Assigns the PCH5 phenotype to compound heterozygous TSEN54 alleles
      including the common p.A307S variant.
  - reference: PMID:20301773
    reference_title: "TSEN54 Pontocerebellar Hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      TSEN54 pontocerebellar hypoplasia (TSEN54-PCH) comprises three PCH
      phenotypes (PCH2, 4, and 5) that share characteristic neuroradiologic and
      neurologic findings.
    explanation: >-
      Places PCH5 among the three TSEN54 phenotypes, which differ mainly in life
      expectancy.
  - reference: PMID:20301773
    reference_title: TSEN54 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      PCH5 resembles PCH4 and has been described in one family.
    explanation: >-
      Sources the single-family report and the clinical overlap with PCH4 stated
      in this row.
- name: PCH7
  display_name: PCH Type 7 (TOE1)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 7
    term:
      id: MONDO:0013993
      label: pontocerebellar hypoplasia type 7
  description: >-
    Pontocerebellar hypoplasia type 7 is caused by biallelic TOE1 variants and
    is distinguished from other PCH subtypes by genital abnormality, presenting
    as PCH with a 46,XY disorder of sex development in individuals with an XY
    karyotype. TOE1 is a deadenylase acting on small nuclear RNAs.
  genes:
  - preferred_term: TOE1
    term:
      id: hgnc:15954
      label: TOE1
  evidence:
  - reference: PMID:38605133
    reference_title: "Role of TOE1 variants at the nuclear localization motif in pontocerebellar hypoplasia 7."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Biallelic TOE1 variants can cause pontocerebellar hypoplasia type 7
      (PCH7), a condition characterized by pontocerebellar hypoplasia with
      genital abnormality.
    explanation: >-
      States the TOE1-PCH7 assignment and the genital feature that distinguishes
      this subtype.
  - reference: PMID:42178111
    reference_title: "Pontocerebellar hypoplasia linked mutations of the deadenylase Target of EGR1 (TOE1) impair thermal stability, ribonuclease activity, and oligomerization."
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: >-
      The Target of EGR1 (TOE1) gene encodes the TOE1 deadenylase, which is
      essential for the maturation of Pol-II transcribed snRNAs in humans.
    explanation: >-
      Sources the deadenylase and snRNA maturation role of TOE1 stated in this row.
- name: PCH8
  display_name: PCH Type 8 (CHMP1A)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 8
    term:
      id: MONDO:0013990
      label: pontocerebellar hypoplasia type 8
  description: >-
    Pontocerebellar hypoplasia type 8 is caused by biallelic loss of function of
    CHMP1A, a member of the ESCRT-III membrane-remodelling complex. The reported
    phenotype combines reduced cerebellar size with microcephaly, and the
    mechanism the cited sources tie to that reduction is failed proliferation of
    cortical and cerebellar progenitors.
  genes:
  - preferred_term: CHMP1A
    term:
      id: hgnc:8740
      label: CHMP1A
  evidence:
  - reference: PMID:23023333
    reference_title: "CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we show that loss-of-function mutations in human CHMP1A cause
      reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral
      cortical size (microcephaly).
    explanation: >-
      Establishes biallelic CHMP1A loss of function as a cause of
      pontocerebellar hypoplasia with microcephaly.
- name: PCH9
  display_name: PCH Type 9 (AMPD2)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia type 9
    term:
      id: MONDO:0014351
      label: pontocerebellar hypoplasia type 9
  description: >-
    Pontocerebellar hypoplasia type 9 is caused by biallelic AMPD2 variants.
    AMPD2 encodes adenosine monophosphate deaminase 2, a purine-metabolism
    enzyme; variants that spare some isoforms have instead been reported in
    spastic paraplegia type 63, so the AMPD2 phenotype depends on which isoforms
    are affected.
  genes:
  - preferred_term: AMPD2
    term:
      id: hgnc:469
      label: AMPD2
  evidence:
  - reference: PMID:29463858
    reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified homozygous or compound heterozygous AMPD2 variants in eight
      PCH-affected individuals from six families.
    explanation: >-
      Reports the biallelic AMPD2 genotypes in PCH-affected individuals that
      define this subtype.
  - reference: PMID:29463858
    reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The existence of various AMPD2 isoforms with different functions possibly
      explains the variability in phenotypes associated with AMPD2 variants:
      variants leaving some of the isoforms intact may cause SPG63, while those
      affecting all isoforms may result in the severe and early-onset PCH9.
    explanation: >-
      Supports the isoform-dependent split between AMPD2-related SPG63 and PCH9
      noted in the description.
- name: PCH11
  display_name: PCH Type 11 (TBC1D23)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 11
    term:
      id: MONDO:0054669
      label: pontocerebellar hypoplasia, type 11
  description: >-
    Pontocerebellar hypoplasia type 11 is caused by biallelic TBC1D23 variants.
    TBC1D23 is a Golgi-localised trafficking adaptor, and PCH11 has been
    reported as a non-degenerative PCH subtype, setting it apart from the
    progressive TSEN and RNA exosome forms.
  genes:
  - preferred_term: TBC1D23
    term:
      id: hgnc:25622
      label: TBC1D23
  evidence:
  - reference: PMID:40581672
    reference_title: "Identification and functional analysis of a novel TBC1D23 pathogenic variant in a Chinese family with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive
      disorder caused by variants in TBC1D23.
    explanation: >-
      States the TBC1D23-PCH11 gene-disease assignment recorded by this row.
  - reference: PMID:28823706
    reference_title: Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report biallelic TBC1D23 mutations in six individuals from four
      unrelated families manifesting a non-degenerative form of PCH.
    explanation: >-
      Sources the non-degenerative character of PCH11 stated in this row.
- name: PCH12
  display_name: PCH Type 12 (COASY)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 12
    term:
      id: MONDO:0032643
      label: pontocerebellar hypoplasia, type 12
  description: >-
    Pontocerebellar hypoplasia type 12 is caused by biallelic COASY variants.
    COASY encodes CoA synthase, which catalyses the final steps of coenzyme A
    biosynthesis; near-complete loss of function gives the perinatal lethal
    PCH12 phenotype, while hypomorphic alleles cause COASY protein-associated
    neurodegeneration.
  genes:
  - preferred_term: COASY
    term:
      id: hgnc:29932
      label: COASY
  evidence:
  - reference: PMID:35499143
    reference_title: "COASY related pontocerebellar hypoplasia type 12: A common Indian mutation with expansion of the phenotypic spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal
      neurodegenerative genetic disorder caused by biallelic mutations in the
      COASY gene.
    explanation: >-
      States the COASY-PCH12 assignment and the perinatal lethal course.
  - reference: PMID:39301217
    reference_title: "CoA synthase plays a critical role in neurodevelopment and neurodegeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Recessive variants of this gene cause an exceptionally rare and devastating
      disease called COASY protein-associated neurodegeneration (CoPAN) while
      complete loss-of-function variants in COASY have been identified in
      fetuses/neonates with Pontocerebellar Hypoplasia type 12 (PCH 12).
    explanation: >-
      Supports the allele-severity split between PCH12 and COASY
      protein-associated neurodegeneration.
- name: PCH14
  display_name: PCH Type 14 (PPIL1)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 14
    term:
      id: MONDO:0030258
      label: pontocerebellar hypoplasia, type 14
  description: >-
    Pontocerebellar hypoplasia type 14 is caused by biallelic PPIL1 variants.
    PPIL1 is a component of the major spliceosome, and the reported phenotype is
    pontocerebellar hypoplasia with microcephaly.
  genes:
  - preferred_term: PPIL1
    term:
      id: hgnc:9260
      label: PPIL1
  evidence:
  - reference: PMID:33220177
    reference_title: "Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients harbored biallelic mutations in genes encoding the spliceosome
      components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA
      Processing-17 (PRP17).
    explanation: >-
      Establishes biallelic PPIL1 variants as a cause of pontocerebellar
      hypoplasia with microcephaly.
- name: PCH16
  display_name: PCH Type 16 (MINPP1)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, type 16
    term:
      id: MONDO:0030438
      label: pontocerebellar hypoplasia, type 16
  description: >-
    Pontocerebellar hypoplasia type 16 is caused by biallelic MINPP1 variants.
    MINPP1 is a multiple inositol polyphosphate phosphatase whose loss allows
    the chelator inositol hexakisphosphate to accumulate intracellularly.
  genes:
  - preferred_term: MINPP1
    term:
      id: hgnc:7102
      label: MINPP1
  evidence:
  - reference: PMID:40508022
    reference_title: "Biallelic Loss-of-Function Variant in MINPP1 Causes Pontocerebellar Hypoplasia with Characteristic Severe Neurodevelopmental Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Multiple subtypes of PCH have been identified, among which the rare
      subtype PCH type 16 is caused by MINPP1 genetic variants.
    explanation: >-
      States the MINPP1-PCH16 gene-disease assignment recorded by this row.
- name: PCH17
  display_name: PCH Type 17 (PRDM13)
  subtype_term:
    preferred_term: pontocerebellar hypoplasia, IIA 17
    term:
      id: MONDO:0030890
      label: pontocerebellar hypoplasia, IIA 17
  description: >-
    Pontocerebellar hypoplasia type 17 is caused by biallelic PRDM13 variants.
    PRDM13 is a transcriptional repressor acting downstream of PTF1A in the
    cerebellar ventricular zone, and the reported phenotype is fatal perinatal
    brainstem dysfunction with cerebellar hypoplasia and a sparse, disorganised
    Purkinje cell layer. A separate PRDM13 phenotype combines cerebellar
    dysfunction with hypogonadotropic hypogonadism.
  genes:
  - preferred_term: PRDM13
    term:
      id: hgnc:13998
      label: PRDM13
  evidence:
  - reference: PMID:35390279
    reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe four families with children presenting with severe neonatal
      brainstem dysfunction and pronounced deficits in cognitive and motor
      development associated with four different bi-allelic mutations in PRDM13,
      including homozygous truncating variants in the most severely affected
      individuals.
    explanation: >-
      Reports the biallelic PRDM13 lesions in a PCH-like perinatal phenotype,
      the basis of this subtype row.
  - reference: PMID:34730112
    reference_title: A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients exhibited intellectual disability, ataxia with cerebellar
      hypoplasia, scoliosis, and delayed puberty with congenital hypogonadotropic
      hypogonadism (CHH).
    explanation: >-
      Sources the separate PRDM13 phenotype combining cerebellar dysfunction with
      hypogonadotropic hypogonadism mentioned in this row.

pathophysiology:
- name: TSEN/CLP1 Dysfunction and Impaired Pre-tRNA Splicing
  description: >
    The tRNA splicing endonuclease (TSEN) complex, composed of TSEN2, TSEN15, TSEN34,
    and TSEN54, cleaves introns from pre-tRNA molecules at the canonical anticodon loop
    position. Mutations in TSEN54 (and other TSEN subunits) impair pre-tRNA processing,
    reducing the pool of mature, functional tRNAs available for translation. Developing
    pontocerebellar neurons have exceptionally high translational demands and are
    disproportionately vulnerable. This mechanism maps primarily to PCH2/PCH4 for TSEN
    genes and to PCH10 for CLP1. The TSEN complex also interacts with CLP1, an RNA
    kinase, reinforcing RNA-processing as the central pathogenic pathway.
  genes:
  - preferred_term: TSEN54
    term:
      id: hgnc:27561
      label: TSEN54
  - preferred_term: TSEN2
    term:
      id: hgnc:28422
      label: TSEN2
  - preferred_term: TSEN34
    term:
      id: hgnc:15506
      label: TSEN34
  - preferred_term: TSEN15
    term:
      id: hgnc:16791
      label: TSEN15
  - preferred_term: CLP1
    term:
      id: hgnc:16999
      label: CLP1
  biological_processes:
  - preferred_term: tRNA splicing via endonucleolytic cleavage and ligation
    term:
      id: GO:0006388
      label: tRNA splicing, via endonucleolytic cleavage and ligation
    modifier: DECREASED
  - preferred_term: translation
    term:
      id: GO:0006412
      label: translation
    modifier: DECREASED
  cell_types:
  - preferred_term: neural stem cell
    term:
      id: CL:0000047
      label: neural stem cell
  - preferred_term: Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  - preferred_term: cerebellar granule cell
    term:
      id: CL:0001031
      label: cerebellar granule cell
  evidence:
  - reference: PMID:18711368
    reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex."
    explanation: Directly establishes that TSEN complex subunit mutations cause PCH2 and PCH4, linking impaired tRNA splicing to disease.
  - reference: PMID:18711368
    reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our findings point to RNA processing as a new basic cellular impairment in neurological disorders."
    explanation: Supports RNA processing deficiency as the central pathogenic mechanism in TSEN-related PCH.
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mutations in three tRNA splicing endonuclease subunit genes were found to be responsible for PCH2, PCH4 and PCH5."
    explanation: Corroborates TSEN complex dysfunction as the molecular basis for the most common PCH subtypes.
  - reference: PMID:24766809
    reference_title: "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Human genome analyses now identified a CLP1 homozygous missense mutation (p.R140H) in five unrelated families, leading to a loss of CLP1 interaction with the tRNA splicing endonuclease (TSEN)
      complex, largely reduced pre-tRNA cleavage activity, and accumulation of linear tRNA introns."
    explanation: Supports CLP1-related PCH10 as a mechanistically linked RNA-processing subtype through impaired TSEN complex interaction and pre-tRNA cleavage.
  downstream:
  - target: Dyskinesia
    description: >-
      TSEN54-related disease is the PCH form in which dyskinesia and dystonia are the
      characteristic movement disorder.
    evidence:
    - reference: PMID:20952379
      reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Mutations in TSEN54 are clinically associated with dyskinesia and/or dystonia
        and variable degrees of spasticity, in some cases with pure generalized
        spasticity.
      explanation: >-
        Ties the TSEN54 lesion carried on this node directly to the dyskinesia
        phenotype.
  - target: Respiratory Insufficiency
    description: >-
      Severe TSEN54 genotypes carry perinatal respiratory failure and ventilator
      dependency.
    evidence:
    - reference: PMID:20952379
      reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Nonsense or splice site mutations in TSEN54 are associated with a more severe
        phenotype of more perinatal symptoms, ventilator dependency and early death.
      explanation: >-
        Ties the severe TSEN54 alleles carried on this node to ventilator dependency.
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: TSEN-complex defects converge on prenatal pontocerebellar maldevelopment with progressive atrophy.
    evidence:
    - reference: PMID:18711368
      reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Pontocerebellar hypoplasias (PCH) represent a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral
        pons"
      explanation: Links TSEN-related PCH to prenatal pontocerebellar hypoplasia and atrophy, supporting the downstream edge.

- name: RNA Exosome Dysfunction (PCH1B/1C/1D)
  description: >
    Biallelic mutations in the structural subunits of the nine-subunit RNA exosome
    impair RNA processing and turnover and cause the PCH1 subtypes: EXOSC3 gives
    PCH1B, EXOSC8 gives PCH1C, and EXOSC9 gives PCH1D. This mechanism produces
    pontocerebellar hypoplasia with spinal muscular atrophy-like weakness and global
    developmental delay, but survival and clinical severity vary by genotype. In
    zebrafish and human cell models, loss of exosome subunits stabilises p53 and
    perturbs ribosome biogenesis, which has been proposed as the route from exosome
    deficiency to the neuronal loss seen in PCH1.
  genes:
  - preferred_term: EXOSC3
    term:
      id: hgnc:17944
      label: EXOSC3
  - preferred_term: EXOSC8
    term:
      id: hgnc:17035
      label: EXOSC8
  - preferred_term: EXOSC9
    term:
      id: hgnc:9137
      label: EXOSC9
  biological_processes:
  - preferred_term: RNA processing
    term:
      id: GO:0006396
      label: RNA processing
    modifier: DECREASED
  - preferred_term: RNA catabolic process
    term:
      id: GO:0006401
      label: RNA catabolic process
    modifier: DECREASED
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  - preferred_term: cerebellar granule cell
    term:
      id: CL:0001031
      label: cerebellar granule cell
  evidence:
  - reference: PMID:23284067
    reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pontocerebellar hypoplasia with spinal muscular atrophy, also known as PCH1, is a group of autosomal recessive disorders characterized by generalized muscle weakness and global developmental
      delay commonly resulting in early death."
    explanation: Defines the PCH1 clinical pattern to which EXOSC3-related PCH1B belongs.
  - reference: PMID:23284067
    reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biallelic mutations in EXOSC3 were detected in 10 of 27 families (37%)."
    explanation: Establishes biallelic EXOSC3 variants as a recurrent cause of PCH1/PCH1B.
  - reference: PMID:33463720
    reference_title: "Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Bi-allelic variants in exosome subunits EXOSC3, EXOSC8 and EXOSC9 have
      been reported to cause pontocerebellar hypoplasia type 1B, type 1C and
      type 1D, respectively, while those in EXOSC2 cause short stature, hearing
      loss, retinitis pigmentosa and distinctive facies.
    explanation: >-
      Assigns all three structural exosome subunits bound on this node to their
      respective PCH1 subtypes.
  - reference: PMID:32527837
    reference_title: RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: >-
      The RNA exosome is a ubiquitously expressed complex of nine core proteins
      (EXOSC1-9) and associated nucleases responsible for RNA processing and
      degradation.
    explanation: >-
      Source for the nine-subunit composition of the complex named in this node's
      description.
  - reference: PMID:32527837
    reference_title: RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Mutations in EXOSC3, EXOSC8, EXOSC9, and the exosome cofactor RBM7 cause
      pontocerebellar hypoplasia and motor neuronopathy.
    explanation: >-
      Groups the three subunits bound on this node as one exosome-level mechanism,
      which is what the node asserts.
  - reference: PMID:32527837
    reference_title: RNA exosome mutations in pontocerebellar hypoplasia alter ribosome biogenesis and p53 levels.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Down-regulation of EXOSC8 and EXOSC9 in human cells leads to p53 protein
      stabilisation and G2/M cell cycle arrest.
    explanation: >-
      Supports the p53 stabilisation step named in this node's description.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: RNA exosome subunit loss converges on pontocerebellar hypoplasia and progressive neurodevelopmental impairment.
    evidence:
    - reference: PMID:23284067
      reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Psychomotor retardation was profound in all patients but lifespan was variable, with 3 subjects surviving beyond the late teens."
      explanation: Supports severe neurodevelopmental impact with variable survival in EXOSC3-related PCH1B.

- name: Mitochondrial tRNA Synthetase Deficiency (PCH6/RARS2)
  description: >
    Mutations in RARS2, encoding the mitochondrial arginyl-tRNA synthetase, reduce
    aminoacylation of mitochondrial tRNA-Arg. This impairs mitochondrial translation,
    decreases oxidative phosphorylation capacity, and leads to energy failure
    preferentially in high-metabolic-demand cells of the developing cerebellum and pons.
    Elevated CSF lactate and reduced respiratory chain complex activity are biochemical
    hallmarks.
  gene:
    preferred_term: RARS2
    term:
      id: hgnc:21406
      label: RARS2
  biological_processes:
  - preferred_term: mitochondrial translation
    term:
      id: GO:0032543
      label: mitochondrial translation
    modifier: DECREASED
  - preferred_term: tRNA aminoacylation for mitochondrial protein translation
    term:
      id: GO:0070127
      label: tRNA aminoacylation for mitochondrial protein translation
    modifier: DECREASED
  cell_types:
  - preferred_term: Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  - preferred_term: cerebellar granule cell
    term:
      id: CL:0001031
      label: cerebellar granule cell
  evidence:
  - reference: PMID:17847012
    reference_title: "Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase"
    explanation: First identification of RARS2 mutations causing PCH, establishing the mitochondrial tRNA synthetase deficiency mechanism.
  - reference: PMID:17847012
    reference_title: "Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mutation was associated with the production of an abnormally short RARS2 transcript and a marked reduction of the mitochondrial tRNA(Arg) transcript in the patients' fibroblasts."
    explanation: Mechanistically links RARS2 mutation to reduced mitochondrial tRNA charging, impairing mitochondrial translation.
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blood and CSF lactate was abnormally elevated in all five patients at early stages"
    explanation: Elevated lactate is a biochemical signature of impaired mitochondrial oxidative phosphorylation due to RARS2 deficiency in PCH6.
  downstream:
  - target: Lactic Acidosis
    description: >-
      Impaired mitochondrial translation raises blood and CSF lactate, the biochemical
      signature that separates PCH6 from the RNA-processing subtypes.
    evidence:
    - reference: PMID:22569581
      reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Blood and CSF lactate was abnormally elevated in all five patients at early
        stages
      explanation: >-
        Reports the elevated lactate that this edge asserts follows from the
        mitochondrial translation defect.
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: RARS2-related mitochondrial translation defects are associated with progressive pontocerebellar and cortical atrophy.
    evidence:
    - reference: PMID:22569581
      reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In three patients follow-up neuroimaging revealed a progressive pontocerebellar and cerebral cortical atrophy."
      explanation: Directly supports progression from RARS2-associated mitochondrial disease to pontocerebellar atrophy.

- name: Anterior Horn Cell Degeneration (PCH1A/VRK1)
  description: >
    In PCH1A, biallelic VRK1 loss-of-function mutations impair nuclear envelope
    formation and RNA processing in post-mitotic neurons. Motor neurons of the anterior
    horn of the spinal cord are additionally affected beyond pontocerebellar neurons,
    producing a spinal muscular atrophy-like clinical picture (hypotonia, muscle weakness,
    areflexia) superimposed on pontocerebellar hypoplasia.
  gene:
    preferred_term: VRK1
    term:
      id: hgnc:12718
      label: VRK1
  biological_processes:
  - preferred_term: nuclear envelope organization
    term:
      id: GO:0006998
      label: nuclear envelope organization
    modifier: DECREASED
  - preferred_term: translation
    term:
      id: GO:0006412
      label: translation
    modifier: DECREASED
  cell_types:
  - preferred_term: motor neuron
    term:
      id: CL:0000100
      label: motor neuron
  evidence:
  - reference: PMID:19646678
    reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"
    explanation: Establishes VRK1 loss-of-function as the causative mutation in PCH1A, which combines pontocerebellar hypoplasia with anterior horn cell degeneration.
  - reference: PMID:19646678
    reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "VRK1, one of three members of the mammalian VRK family, is a serine/threonine kinase that phosphorylates p53 and CREB and is essential for nuclear envelope formation."
    explanation: VRK1's role in nuclear envelope formation explains its neuronal vulnerability phenotype in PCH1A.
  downstream:
  - target: Hypotonia
    description: >-
      Anterior horn cell loss produces the muscle weakness and hypotonia that define
      the SMA-like component of PCH1.
    evidence:
    - reference: PMID:19646678
      reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: BACKGROUND
      snippet: >-
        The spinal muscular atrophies (SMAs) are a genetically and clinically
        heterogeneous group of disorders characterized by degeneration and loss of
        anterior horn cells in the spinal cord, leading to muscle weakness and
        atrophy.
      explanation: >-
        States the causal step from anterior horn cell loss to muscle weakness that
        this edge asserts.
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: VRK1-associated SMA-PCH combines anterior horn cell degeneration with pontocerebellar hypoplasia.
    evidence:
    - reference: PMID:19646678
      reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"
      explanation: Establishes VRK1 loss as causal for the combined spinal muscular atrophy and pontocerebellar hypoplasia phenotype.

- name: Spliceosome and snRNA Maturation Failure
  description: >-
    Two PCH genes act on the maturation and function of small nuclear RNAs and
    the major spliceosome rather than on tRNA. TOE1 is a deadenylase that trims
    snRNA 3' ends, and PPIL1 is a peptidyl-prolyl isomerase component of the
    spliceosome. These are two steps in one pathway rather than two categories:
    the snRNAs TOE1 matures are components of the spliceosome PPIL1 belongs to,
    so biallelic loss of either gene converges on the same defect, loss of
    splicing integrity in developing neurons, giving PCH7 and PCH14
    respectively.
  genes:
  - preferred_term: TOE1
    term:
      id: hgnc:15954
      label: TOE1
  - preferred_term: PPIL1
    term:
      id: hgnc:9260
      label: PPIL1
  biological_processes:
  - preferred_term: snRNA processing
    term:
      id: GO:0016180
      label: snRNA processing
    modifier: DECREASED
  - preferred_term: mRNA splicing, via spliceosome
    term:
      id: GO:0000398
      label: mRNA splicing, via spliceosome
    modifier: DECREASED
  evidence:
  - reference: PMID:42178111
    reference_title: "Pontocerebellar hypoplasia linked mutations of the deadenylase Target of EGR1 (TOE1) impair thermal stability, ribonuclease activity, and oligomerization."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Over a dozen missense mutations in the TOE1 gene have been linked to
      Pontocerebellar Hypoplasia Type seven (PCH7), a rare but serious
      neurodevelopmental and neurodegenerative disease that leads to early
      mortality.
    explanation: >-
      Links TOE1 ribonuclease variants to PCH7, one of the two subtypes this
      node groups.
  - reference: PMID:33220177
    reference_title: "Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients harbored biallelic mutations in genes encoding the spliceosome
      components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA
      Processing-17 (PRP17).
    explanation: >-
      Identifies PPIL1 as a spliceosome component mutated in pontocerebellar
      hypoplasia with microcephaly.
  - reference: PMID:33220177
    reference_title: "Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Loss of either protein affected splicing integrity, predominantly
      affecting short and high GC-content introns and genes involved in brain
      disorders.
    explanation: >-
      Supports impaired splicing integrity as the shared molecular consequence
      asserted by this node.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Failure of snRNA maturation and spliceosome function in developing
      hindbrain neurons converges on the shared pontocerebellar endpoint.
    evidence:
    - reference: PMID:33220177
      reference_title: "Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Mouse knockouts of either gene were lethal in early embryogenesis,
        whereas PPIL1 patient mutation knockin mice showed neuron-specific
        apoptosis.
      explanation: >-
        Shows that the splicing defect selectively kills neurons, the step
        linking this node to cerebellar degeneration.
- name: ESCRT-III Dysfunction and Impaired Progenitor Proliferation
  description: >-
    CHMP1A is a subunit of the ESCRT-III membrane-remodelling complex. In null
    mice, loss of Chmp1a impairs intraluminal vesicle formation in multivesicular
    bodies and Sonic hedgehog secretion, and the cortical and cerebellar
    progenitors fail to proliferate; in patient cells the proliferation defect
    tracks increased INK4A expression and loss of its normal BMI1 repression.
    Biallelic loss of function gives PCH8. The proliferation arm rather than the
    trafficking arm is what the cited sources tie to reduced cerebellar size, so
    this node is kept separate from the TBC1D23 Golgi node.
  genes:
  - preferred_term: CHMP1A
    term:
      id: hgnc:8740
      label: CHMP1A
  biological_processes:
  - preferred_term: multivesicular body assembly
    term:
      id: GO:0036258
      label: multivesicular body assembly
    modifier: DECREASED
  - preferred_term: neural precursor cell proliferation
    term:
      id: GO:0061351
      label: neural precursor cell proliferation
    modifier: DECREASED
  evidence:
  - reference: PMID:23023333
    reference_title: "CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we show that loss-of-function mutations in human CHMP1A cause
      reduced cerebellar size (pontocerebellar hypoplasia) and reduced
      cerebral cortical size (microcephaly).
    explanation: >-
      Establishes CHMP1A loss of function as a cause of pontocerebellar
      hypoplasia.
  - reference: PMID:23023333
    reference_title: "CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      CHMP1A-mutant cells show impaired proliferation, with increased
      expression of INK4A, a negative regulator of stem cell proliferation.
    explanation: >-
      Sources the impaired proliferation and INK4A derepression named in this
      node's description.
  - reference: PMID:23023333
    reference_title: "CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Chromatin immunoprecipitation suggests loss of the normal INK4A repression
      by BMI in these cells.
    explanation: >-
      Sources the loss of BMI1 repression of INK4A named in this node's
      description.
  - reference: PMID:30044992
    reference_title: "The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We recently showed human loss-of-function (LOF) mutations in ESCRT-III
      member CHMP1A cause autosomal recessive microcephaly with
      pontocerebellar hypoplasia, but its mechanism was unclear.
    explanation: >-
      Places CHMP1A in the ESCRT-III complex, the molecular identity this node
      asserts.
  - reference: PMID:30044992
    reference_title: "The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In Chmp1a null mice, this defect is associated with impaired sonic
      hedgehog (Shh) secretion and intraluminal vesicle (ILV) formation in
      multivesicular bodies (MVBs).
    explanation: >-
      Sources the multivesicular body process bound on this node.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Failure of cortical and cerebellar progenitor proliferation converges on the
      shared pontocerebellar endpoint.
    evidence:
    - reference: PMID:30044992
      reference_title: "The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Here, we show Chmp1a is required for progenitor proliferation in mouse
        cortex and cerebellum and progenitor maintenance in human cerebral
        organoids.
      explanation: >-
        Ties loss of CHMP1A to failure of cerebellar progenitor proliferation,
        the step this edge asserts.
    - reference: PMID:23023333
      reference_title: "CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Here, we show that loss-of-function mutations in human CHMP1A cause
        reduced cerebellar size (pontocerebellar hypoplasia) and reduced
        cerebral cortical size (microcephaly).
      explanation: >-
        Directly links CHMP1A loss of function to reduced cerebellar size.
- name: Golgi Trafficking Failure
  description: >-
    TBC1D23 is a Golgi-localised adaptor that bridges endosome-derived vesicles to
    golgins during retrograde transport and is required for LKB1 signalling at the
    Golgi. Biallelic loss gives PCH11, which has been reported as a
    non-degenerative PCH subtype with postnatal rather than prenatal cerebellar
    change, setting it apart from the RNA-processing forms.
  genes:
  - preferred_term: TBC1D23
    term:
      id: hgnc:25622
      label: TBC1D23
  biological_processes:
  - preferred_term: retrograde transport, endosome to Golgi
    term:
      id: GO:0042147
      label: retrograde transport, endosome to Golgi
    modifier: DECREASED
  evidence:
  - reference: PMID:38413626
    reference_title: "TBC1D23 mediates Golgi-specific LKB1 signaling."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      TBC1D23, a Golgi-localized protein that is frequently mutated in the
      neurodevelopment disorder pontocerebellar hypoplasia (PCH), is
      specifically required for the LKB1 signaling at the Golgi.
    explanation: >-
      Establishes TBC1D23 as a Golgi-localised protein mutated in PCH and names
      the signalling role stated in this node.
  - reference: PMID:40581672
    reference_title: "Identification and functional analysis of a novel TBC1D23 pathogenic variant in a Chinese family with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive
      disorder caused by variants in TBC1D23.
    explanation: >-
      Establishes the TBC1D23-PCH11 gene-disease assignment behind this node.
  - reference: PMID:28823706
    reference_title: "Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report biallelic TBC1D23 mutations in six individuals from four
      unrelated families manifesting a non-degenerative form of PCH.
    explanation: >-
      Sources the non-degenerative character of PCH11 stated in this node.
  - reference: PMID:38413626
    reference_title: "TBC1D23 mediates Golgi-specific LKB1 signaling."
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: >-
      TBC1D23 was previously identified as a bridging factor for endosome-derived
      vesicles and golgins at Trans-Golgi Network (TGN)
    explanation: >-
      Sources the bridging role between endosome-derived vesicles and golgins
      stated in this node's description.
  - reference: PMID:32360255
    reference_title: "Pontocerebellar hypoplasia type 11: Does the genetic defect determine timing of cerebellar pathology?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While pontine hypoplasia and pronounced microcephaly are in line with
      previous reports on PCH11, our observations of clearly postnatal atrophy of
      the cerebellum argues for a different pathomechanism than in the other
      forms of PCH and supports the hypothesis that TBC1D23 deficiency
      predominantly interferes with postnatal rather than with prenatal
      cerebellar development.
    explanation: >-
      Sources the postnatal rather than prenatal timing of the cerebellar change
      in PCH11, which separates it from the other subtypes on this entry.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Loss of Golgi-directed retrograde trafficking converges on the shared
      pontocerebellar endpoint, though in this subtype the cerebellar change is
      reported as postnatal rather than prenatal.
    evidence:
    - reference: PMID:28823706
      reference_title: "Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Altogether, this study provides a causative link between TBC1D23
        mutations and PCH and suggests a less severe clinical course than other
        PCH subtypes.
      explanation: >-
        Links TBC1D23 loss to the pontocerebellar phenotype and to its milder
        course.
    - reference: PMID:32360255
      reference_title: "Pontocerebellar hypoplasia type 11: Does the genetic defect determine timing of cerebellar pathology?"
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        While pontine hypoplasia and pronounced microcephaly are in line with
        previous reports on PCH11, our observations of clearly postnatal atrophy
        of the cerebellum argues for a different pathomechanism than in the other
        forms of PCH and supports the hypothesis that TBC1D23 deficiency
        predominantly interferes with postnatal rather than with prenatal
        cerebellar development.
      explanation: >-
        Sources the postnatal timing this edge's description asserts.
- name: Mitochondrial Membrane Dynamics Disruption
  description: >-
    SLC25A46 encodes a mitochondrial outer-membrane protein that tunes
    mitochondrial fission and fusion. Complete loss of function gives the lethal
    congenital PCH1E phenotype, while milder alleles of the same gene cause
    optic atrophy and hereditary motor and sensory neuropathy, so the severity
    of the PCH phenotype tracks the severity of the allele.
  genes:
  - preferred_term: SLC25A46
    term:
      id: hgnc:25198
      label: SLC25A46
  biological_processes:
  - preferred_term: mitochondrial fusion
    term:
      id: GO:0008053
      label: mitochondrial fusion
    modifier: DECREASED
  evidence:
  - reference: PMID:27543974
    reference_title: "Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In siblings from two unrelated families who died soon after birth with a
      profound neurodevelopmental disorder characterized by pontocerebellar
      hypoplasia and apnoea, we discovered a missense mutation and an exonic
      deletion in the SLC25A46 gene encoding a mitochondrial protein recently
      implicated in optic atrophy spectrum disorder.
    explanation: >-
      Reports the biallelic SLC25A46 lesions in lethal congenital
      pontocerebellar hypoplasia.
  - reference: PMID:27543974
    reference_title: "Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This genotype-phenotype correlation underscores the importance of
      SLC25A46 and fine tuning of mitochondrial fission and fusion in
      pontocerebellar hypoplasia and central neurodevelopment in addition to
      optic and peripheral neuropathy across the life span.
    explanation: >-
      Names mitochondrial fission and fusion as the process this node asserts
      is disrupted.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Loss of mitochondrial membrane dynamics in developing hindbrain neurons
      converges on the shared pontocerebellar endpoint.
    evidence:
    - reference: PMID:27543974
      reference_title: "Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        This genotype-phenotype correlation underscores the importance of
        SLC25A46 and fine tuning of mitochondrial fission and fusion in
        pontocerebellar hypoplasia and central neurodevelopment in addition to
        optic and peripheral neuropathy across the life span.
      explanation: >-
        Ties the mitochondrial dynamics defect to pontocerebellar hypoplasia and
        central neurodevelopment.
- name: Coenzyme A Biosynthesis Deficiency
  description: >-
    COASY encodes CoA synthase, which carries out the last steps of de novo
    coenzyme A biosynthesis. Near-complete loss of function gives the perinatal
    lethal PCH12 phenotype, whereas hypomorphic COASY alleles cause COASY
    protein-associated neurodegeneration, a form of neurodegeneration with brain
    iron accumulation.
  genes:
  - preferred_term: COASY
    term:
      id: hgnc:29932
      label: COASY
  biological_processes:
  - preferred_term: coenzyme A biosynthetic process
    term:
      id: GO:0015937
      label: coenzyme A biosynthetic process
    modifier: DECREASED
  evidence:
  - reference: PMID:35499143
    reference_title: "COASY related pontocerebellar hypoplasia type 12: A common Indian mutation with expansion of the phenotypic spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal
      neurodegenerative genetic disorder caused by biallelic mutations in the
      COASY gene.
    explanation: >-
      Establishes biallelic COASY mutation as the cause of PCH12.
  - reference: PMID:39301217
    reference_title: "CoA synthase plays a critical role in neurodevelopment and neurodegeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Recessive variants of this gene cause an exceptionally rare and devastating
      disease called COASY protein-associated neurodegeneration (CoPAN) while
      complete loss-of-function variants in COASY have been identified in
      fetuses/neonates with Pontocerebellar Hypoplasia type 12 (PCH 12).
    explanation: >-
      Supports the allele-severity split between PCH12 and COASY
      protein-associated neurodegeneration stated in this node.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Failure of coenzyme A supply in the developing hindbrain converges on
      the shared pontocerebellar endpoint.
    evidence:
    - reference: PMID:35499143
      reference_title: "COASY related pontocerebellar hypoplasia type 12: A common Indian mutation with expansion of the phenotypic spectrum."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: BACKGROUND
      snippet: >-
        Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal
        neurodegenerative genetic disorder caused by biallelic mutations in the
        COASY gene.
      explanation: >-
        Links loss of CoA synthase directly to the pontocerebellar hypoplasia
        endpoint.
- name: Purine Nucleotide Metabolism Failure
  description: >-
    AMPD2 encodes adenosine monophosphate deaminase 2, which converts AMP to
    IMP. Variants that disable all isoforms give the severe early-onset PCH9
    phenotype, whereas variants that leave some isoforms intact have instead
    been reported in spastic paraplegia type 63.
  genes:
  - preferred_term: AMPD2
    term:
      id: hgnc:469
      label: AMPD2
  biological_processes:
  - preferred_term: AMP catabolic process
    term:
      id: GO:0006196
      label: AMP catabolic process
    modifier: DECREASED
  evidence:
  - reference: PMID:29463858
    reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified homozygous or compound heterozygous AMPD2 variants in
      eight PCH-affected individuals from six families.
    explanation: >-
      Establishes biallelic AMPD2 variants as a cause of pontocerebellar
      hypoplasia.
  - reference: PMID:29463858
    reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The existence of various AMPD2 isoforms with different functions
      possibly explains the variability in phenotypes associated with AMPD2
      variants: variants leaving some of the isoforms intact may cause SPG63,
      while those affecting all isoforms may result in the severe and
      early-onset PCH9.
    explanation: >-
      Supports the isoform-dependent phenotype split stated in this node's
      description.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Loss of AMP deaminase activity in developing hindbrain neurons converges
      on the shared pontocerebellar endpoint.
    evidence:
    - reference: PMID:29463858
      reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified homozygous or compound heterozygous AMPD2 variants in
        eight PCH-affected individuals from six families.
      explanation: >-
        Links biallelic AMPD2 loss to the pontocerebellar phenotype.
- name: Inositol Polyphosphate Metabolism Failure
  description: >-
    MINPP1 is a multiple inositol polyphosphate phosphatase. Biallelic loss of
    function allows the chelator inositol hexakisphosphate to accumulate inside
    cells, which has been proposed as the route to the PCH16 phenotype.
  genes:
  - preferred_term: MINPP1
    term:
      id: hgnc:7102
      label: MINPP1
  biological_processes:
  - preferred_term: inositol phosphate catabolic process
    term:
      id: GO:0071545
      label: inositol phosphate catabolic process
    modifier: DECREASED
  evidence:
  - reference: PMID:40508022
    reference_title: "Biallelic Loss-of-Function Variant in MINPP1 Causes Pontocerebellar Hypoplasia with Characteristic Severe Neurodevelopmental Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Multiple subtypes of PCH have been identified, among which the rare
      subtype PCH type 16 is caused by MINPP1 genetic variants.
    explanation: >-
      Establishes MINPP1 as the PCH16 gene.
  - reference: PMID:33257696
    reference_title: "MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These data suggest the involvement of IP6-mediated chelation on
      Pontocerebellar Hypoplasia disease pathology and thereby highlight the
      critical role of MINPP1 in the regulation of human brain development and
      homeostasis.
    explanation: >-
      Supports inositol hexakisphosphate accumulation as the proposed
      mechanism stated in this node.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Accumulation of inositol hexakisphosphate in developing brain cells
      converges on the shared pontocerebellar endpoint.
    evidence:
    - reference: PMID:33257696
      reference_title: "MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        These data suggest the involvement of IP6-mediated chelation on
        Pontocerebellar Hypoplasia disease pathology and thereby highlight the
        critical role of MINPP1 in the regulation of human brain development and
        homeostasis.
      explanation: >-
        Ties the inositol polyphosphate defect to pontocerebellar hypoplasia
        pathology.
- name: Cerebellar GABAergic Neuron Specification Failure
  description: >-
    PRDM13 is a transcriptional repressor expressed in progenitors of the
    cerebellar ventricular zone, which give rise to the cerebellar GABAergic
    neurons including Purkinje cells. Biallelic PRDM13 loss produces a PCH-like
    phenotype with hypoplasia of the inferior olive, dysplasia of the dentate
    nucleus, and a sparse, disorganised Purkinje cell layer, so the lesion here
    is a failure of neuronal specification rather than of a housekeeping
    process.
  genes:
  - preferred_term: PRDM13
    term:
      id: hgnc:13998
      label: PRDM13
  biological_processes:
  - preferred_term: GABAergic neuron differentiation
    term:
      id: GO:0097154
      label: GABAergic neuron differentiation
    modifier: DECREASED
  - preferred_term: cerebellar Purkinje cell differentiation
    term:
      id: GO:0021702
      label: cerebellar Purkinje cell differentiation
    modifier: DECREASED
  evidence:
  - reference: PMID:35390279
    reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe four families with children presenting with severe neonatal
      brainstem dysfunction and pronounced deficits in cognitive and motor
      development associated with four different bi-allelic mutations in
      PRDM13, including homozygous truncating variants in the most severely
      affected individuals.
    explanation: >-
      Establishes biallelic PRDM13 mutation as the cause of this PCH-like
      phenotype.
  - reference: PMID:35390279
    reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Brain MRI and fetopathological examination revealed a PCH-like
      phenotype, associated with major hypoplasia of inferior olive nuclei and
      dysplasia of the dentate nucleus.
    explanation: >-
      Sources the inferior olive and dentate findings named in this node's
      description.
  - reference: PMID:35390279
    reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Notably, histopathological examinations highlighted a sparse and
      disorganized Purkinje cell layer in the cerebellum.
    explanation: >-
      Sources the Purkinje cell layer finding named in this node's
      description.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Failure to specify cerebellar GABAergic neurons converges on the shared
      pontocerebellar endpoint.
    evidence:
    - reference: PMID:35390279
      reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        snRNA-seq data mining and in situ hybridization in humans show that
        PRDM13 is expressed at early stages in the progenitors of the cerebellar
        ventricular zone, which gives rise to cerebellar GABAergic neurons,
        including Purkinje cells.
      explanation: >-
        Places PRDM13 in the cerebellar progenitors whose failure produces the
        hypoplastic cerebellum.
- name: Presynaptic Active Zone Assembly Failure
  description: >-
    PCLO encodes Piccolo, a scaffold protein of the presynaptic active zone.
    Biallelic nonsense PCLO variants underlie PCH3, historically described as
    cerebellar atrophy with progressive microcephaly, making PCH3 a synaptic
    rather than an RNA-processing or metabolic mechanism.
  genes:
  - preferred_term: PCLO
    term:
      id: hgnc:13406
      label: PCLO
  biological_processes:
  - preferred_term: presynaptic active zone organization
    term:
      id: GO:1990709
      label: presynaptic active zone organization
    modifier: DECREASED
  - preferred_term: neurotransmitter secretion
    term:
      id: GO:0007269
      label: neurotransmitter secretion
    modifier: DECREASED
  evidence:
  - reference: PMID:25832664
    reference_title: "Loss of PCLO function underlies pontocerebellar hypoplasia type III."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we show that a homozygous, nonsense PCLO mutation underlies the
      autosomal recessive neurodegenerative disorder, PCH3.
    explanation: >-
      Establishes biallelic PCLO loss of function as the cause of PCH3.
  downstream:
  - target: Impaired Cerebellar Development and Progressive Degeneration
    description: >-
      Loss of presynaptic active zone scaffolding converges on the shared
      pontocerebellar endpoint.
    evidence:
    - reference: PMID:25832664
      reference_title: "Loss of PCLO function underlies pontocerebellar hypoplasia type III."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Here, we show that a homozygous, nonsense PCLO mutation underlies the
        autosomal recessive neurodegenerative disorder, PCH3.
      explanation: >-
        Links loss of the active zone scaffold to the PCH3 neurodegenerative
        phenotype.

- name: Impaired Cerebellar Development and Progressive Degeneration
  description: >
    Convergent downstream consequence of TSEN complex dysfunction, mitochondrial
    tRNA synthetase deficiency, and motor neuron degeneration. Pontocerebellar
    neurons fail to develop normally in utero (prenatal onset), followed by progressive
    postnatal degeneration. Neuropathology shows reduced cerebellar volume, simplified
    or absent foliation, and hypoplastic pons with loss of pontine nuclei. The cerebral
    cortex is relatively spared. MRI shows the characteristic dragonfly or butterfly
    sign of hypoplastic cerebellar hemispheres with preserved vermis in PCH2.
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The common characteristics are cerebellar hypoplasia with variable atrophy of the cerebellum and the ventral pons."
    explanation: Confirms cerebellar and pontine hypoplasia as the universal neuropathological endpoint across PCH subtypes.
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found a strong correlation (P < 0.0005) between TSEN54 mutations and a dragonfly-like cerebellar pattern on magnetic resonance imaging, in which the cerebellar hemispheres are flat and
      severely reduced in size and the vermis is relatively spared."
    explanation: Establishes the characteristic dragonfly MRI pattern as a radiological correlate of the cerebellar degeneration in TSEN54-related PCH.
  downstream:
  - target: Cerebellar Hypoplasia
    description: >-
      Cerebellar hypoplasia with prenatal onset and progressive postnatal atrophy is the cardinal structural consequence of the converged mechanism.
    evidence:
    - reference: PMID:21749694
      reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        All subtypes share common characteristics, including hypoplasia/atrophy of
        cerebellum and pons, progressive microcephaly, and variable cerebral
        involvement.
      explanation: >-
        Names cerebellar hypoplasia as a characteristic shared across all PCH subtypes.
  - target: Hypoplasia of the Pons
    description: >-
      Loss of pontine nuclei and transverse fibres accompanies the cerebellar lesion in most subtypes.
    evidence:
    - reference: PMID:21749694
      reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        All subtypes share common characteristics, including hypoplasia/atrophy of
        cerebellum and pons, progressive microcephaly, and variable cerebral
        involvement.
      explanation: >-
        Names pontine hypoplasia or atrophy as a characteristic shared across all PCH subtypes.
  - target: Progressive Microcephaly
    description: >-
      Continuing postnatal degeneration produces head growth that falls progressively away from the normal range.
    evidence:
    - reference: PMID:21749694
      reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        All subtypes share common characteristics, including hypoplasia/atrophy of
        cerebellum and pons, progressive microcephaly, and variable cerebral
        involvement.
      explanation: >-
        Names progressive microcephaly as a characteristic shared across all PCH subtypes.
  - target: Severe Intellectual Disability
    description: >-
      Failure of pontocerebellar development and ongoing degeneration leave profound cognitive impairment.
    evidence:
    - reference: PMID:21749694
      reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Patients have severe cognitive and motor handicaps and seizures are often
        reported.
      explanation: >-
        States that patients have severe cognitive handicaps.
  - target: Seizures
    description: >-
      Cortical and subcortical involvement accompanying the pontocerebellar lesion gives rise to seizures in a large fraction of patients.
    evidence:
    - reference: PMID:21749694
      reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Patients have severe cognitive and motor handicaps and seizures are often
        reported.
      explanation: >-
        States that seizures are often reported in PCH.
  - target: Progressive Neurodegeneration and Poor Survival
    description: >-
      Degeneration continues after birth and determines the poor prognosis of the group.
    evidence:
    - reference: PMID:21749694
      reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Treatment is only symptomatic and prognosis is poor, as most patients die
        during infancy or childhood.
      explanation: >-
        States the poor prognosis and early mortality of the group.
  - target: Feeding Difficulties
    description: >-
      Bulbar dysfunction from the pontocerebellar lesion impairs sucking and
      swallowing from the neonatal period onward.
    evidence:
    - reference: PMID:22569581
      reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The long-term follow-up revealed a virtual absence of psychomotor development,
        progressive microcephaly, and feeding difficulties.
      explanation: >-
        Reports the feeding difficulties that this edge asserts follow from the
        converged pontocerebellar lesion.

phenotypes:
- name: Cerebellar Hypoplasia
  category: Neurological
  description: >
    Hypoplasia of the cerebellum is the cardinal structural finding, present in all PCH
    types. Prenatal onset with progressive postnatal atrophy. In PCH2, the characteristic
    "dragonfly" MRI pattern shows flat, severely reduced cerebellar hemispheres with
    relative sparing of the vermis.
  phenotype_term:
    preferred_term: Cerebellar hypoplasia
    term:
      id: HP:0001321
      label: Cerebellar hypoplasia
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All subtypes share common characteristics, including hypoplasia/atrophy of cerebellum and pons, progressive microcephaly, and variable cerebral involvement."
    explanation: Confirms cerebellar hypoplasia/atrophy as a shared characteristic of all PCH subtypes.

- name: Hypoplasia of the Pons
  category: Neurological
  description: Pontine hypoplasia accompanies cerebellar hypoplasia in most PCH types, reflecting degeneration of pontine nuclei and transverse pontine fibres.
  phenotype_term:
    preferred_term: Hypoplasia of the pons
    term:
      id: HP:0012110
      label: Hypoplasia of the pons
  frequency: FREQUENT
  evidence:
  - reference: PMID:18711368
    reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pontocerebellar hypoplasias (PCH) represent a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral
      pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments."
    explanation: Establishes pontine hypoplasia as part of the core neuropathological phenotype defining PCH.

- name: Progressive Microcephaly
  category: Neurological
  description: >
    Progressive postnatal microcephaly, most prominent in PCH2, reflecting ongoing
    neurodegeneration rather than a pure developmental failure. Head circumference is
    often normal or near-normal at birth and decreases progressively.
  phenotype_term:
    preferred_term: Progressive microcephaly
    term:
      id: HP:0000253
      label: Progressive microcephaly
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All subtypes share common characteristics, including hypoplasia/atrophy of cerebellum and pons, progressive microcephaly, and variable cerebral involvement."
    explanation: Establishes progressive microcephaly as a common feature across PCH subtypes.
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."
    explanation: Documents progressive microcephaly in PCH6 (RARS2) patients on long-term follow-up.

- name: Dyskinesia
  category: Neurological
  description: >
    Hyperkinetic movement disorder with chorea and dystonia, characteristic of PCH2.
    Dyskinesia is associated with TSEN54 mutations and can be a prominent presenting
    feature in the first months of life.
  phenotype_term:
    preferred_term: Dyskinesia
    term:
      id: HP:0100660
      label: Dyskinesia
  frequency: FREQUENT
  subtype: PCH2
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mutations in TSEN54 are clinically associated with dyskinesia and/or dystonia and variable degrees of spasticity, in some cases with pure generalized spasticity."
    explanation: Directly links TSEN54 mutations (PCH2) to dyskinesia and dystonia as characteristic clinical features.

- name: Seizures
  category: Neurological
  description: >
    Epileptic seizures occur across PCH subtypes, particularly PCH2 and PCH6. In PCH6,
    neonatal or early-infantile epileptic encephalopathy with intractable seizures is
    the presenting feature.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  frequency: FREQUENT
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients have severe cognitive and motor handicaps and seizures are often reported."
    explanation: Confirms seizures as a frequently reported feature across PCH subtypes.
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures."
    explanation: Establishes early-onset intractable epilepsy as a defining feature of PCH6 (RARS2 mutations).

- name: Feeding Difficulties
  category: Neurological
  description: >
    Feeding difficulty is a common severe-care feature in PCH, reflecting profound
    neurodevelopmental impairment, hypotonia, dysphagia, and respiratory vulnerability.
    In RARS2-related PCH6 it accompanies progressive microcephaly and virtual absence
    of psychomotor development.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  frequency: FREQUENT
  evidence:
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."
    explanation: Documents feeding difficulties as part of the PCH6 clinical spectrum.

- name: Severe Intellectual Disability
  category: Neurological
  description: >
    Profound intellectual disability is universal across PCH subtypes. Independent
    ambulation and meaningful speech are rarely if ever achieved. Cognitive development
    typically stalls in the first year of life.
  phenotype_term:
    preferred_term: Profound intellectual disability
    term:
      id: HP:0002187
      label: Profound intellectual disability
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:18711368
    reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pontocerebellar hypoplasias (PCH) represent a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral
      pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments."
    explanation: Establishes severe mental impairments as part of the defining phenotype of PCH.
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."
    explanation: Documents virtual absence of psychomotor development (equivalent to profound intellectual disability) in PCH6.

- name: Hypotonia
  category: Neurological
  description: >
    Neonatal and infantile hypotonia, often severe, contributing to feeding difficulties,
    respiratory compromise, and absence of motor milestones. In PCH1A, hypotonia is
    compounded by anterior horn cell degeneration.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:19646678
    reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of disorders characterized by degeneration and loss of anterior horn cells in the spinal cord, leading
      to muscle weakness and atrophy."
    explanation: VRK1 loss-of-function causes SMA-PCH (PCH1A) with degeneration of anterior horn cells, producing hypotonia and muscle weakness as core features.

- name: Respiratory Insufficiency
  category: Pulmonary
  description: >
    Respiratory insufficiency due to combined central and peripheral causes. In PCH1A,
    anterior horn cell loss causes ventilatory muscle weakness; in PCH4, neonatal
    respiratory failure is the immediate cause of death. In PCH2, severe cases with
    nonsense TSEN54 mutations may require ventilator dependency.
  phenotype_term:
    preferred_term: Respiratory insufficiency
    term:
      id: HP:0002093
      label: Respiratory insufficiency
  frequency: FREQUENT
  subtypes:
  - PCH1A
  - PCH4
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nonsense or splice site mutations in TSEN54 are associated with a more severe phenotype of more perinatal symptoms, ventilator dependency and early death."
    explanation: Documents respiratory insufficiency severe enough to require ventilator support in PCH4 patients with null TSEN54 alleles.

- name: Lactic Acidosis
  category: Metabolic
  description: >
    Elevated blood or CSF lactate is a mitochondrial-disease clue in RARS2-related PCH6,
    although later reports indicate that lactate can be absent in some genetically
    confirmed patients.
  phenotype_term:
    preferred_term: Lactic acidosis
    term:
      id: HP:0003128
      label: Lactic acidosis
  frequency: FREQUENT
  subtype: PCH6
  evidence:
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blood and CSF lactate was abnormally elevated in all five patients at early stages"
    explanation: Supports elevated lactate as a frequent early biochemical feature in the original PCH6 cohort.

- name: Progressive Neurodegeneration and Poor Survival
  category: Neurological
  description: >
    PCH has a poor prognosis overall, with death in infancy or childhood for many
    affected individuals. Survival varies by subtype and genotype; EXOSC3-related
    PCH1B can include longer survival, while severe TSEN54-related PCH4 is often
    neonatal lethal.
  phenotype_term:
    preferred_term: Neurodegeneration
    clinical_course: PROGRESSIVE
    term:
      id: HP:0002180
      label: Neurodegeneration
  frequency: FREQUENT
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Treatment is only symptomatic and prognosis is poor, as most patients die during infancy or childhood."
    explanation: Supports poor survival as a major prognostic feature of PCH.
  - reference: PMID:23284067
    reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "EXOSC3 mutations account for 30%-40% of patients with PCH1 with variability in survival and clinical severity that is correlated with the genotype."
    explanation: Clarifies that survival is subtype- and genotype-dependent, especially within PCH1B.

genetic:
- name: TSEN54 mutations (PCH2, PCH4)
  gene_term:
    preferred_term: TSEN54
    term:
      id: hgnc:27561
      label: TSEN54
  association: Causative
  notes: >
    Mutations in TSEN54, encoding the 54 kDa subunit of the TSEN complex, cause the
    most common forms of PCH (types 2 and 4). The founder missense allele
    c.919G>T (p.Ala307Ser) is present in the majority of PCH2 patients of European
    ancestry, often in homozygous form. Biallelic null or severe compound alleles
    cause the neonatal lethal PCH4 phenotype, and compound heterozygosity for
    p.Ala307Ser plus a splice-site allele has been reported in PCH5. Mutations in
    other TSEN subunits cause rarer PCH2 subtypes: TSEN2 gives PCH2B, TSEN34 gives
    PCH2C and TSEN15 gives PCH2F. PCH2D is caused by SEPSECS, not by a TSEN subunit.
    The scalar `subtype` slot is left unset on this record because TSEN54 spans the
    PCH2A, PCH4 and PCH5 rows in `has_subtypes` rather than a single one.
  evidence:
  - reference: PMID:18711368
    reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex."
    explanation: Establishes TSEN complex subunit mutations (predominantly TSEN54) as causative for PCH2 and PCH4.
  - reference: PMID:20803644
    reference_title: "Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This mutation results in an amino acid substitution of alanine for serine
      at codon 307 (A307S), and it has previously been described in a Northern
      European subset of patients with PCH2
    explanation: >-
      Sources the p.Ala307Ser founder allele and its Northern European ancestry
      association stated in these notes.
  - reference: PMID:21368912
    reference_title: TSEN54 mutations cause pontocerebellar hypoplasia type 5.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The PCH5 patient was found to be the result of compound heterozygosity for
      the common TSEN54 mutation (p.A307S) plus a novel splice site mutation.
    explanation: >-
      Sources the PCH5 genotype named in these notes and the third TSEN54 subtype
      this record spans.
  - reference: PMID:27392077
    reference_title: Autosomal-Recessive Mutations in the tRNA Splicing Endonuclease Subunit TSEN15 Cause Pontocerebellar Hypoplasia and Progressive Microcephaly.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report three homozygous TSEN15 variants that cause a milder version
      of PCH2.
    explanation: >-
      Sources the TSEN15 PCH2 subtype named in these notes.

- name: VRK1 mutations (PCH1A)
  gene_term:
    preferred_term: VRK1
    term:
      id: hgnc:12718
      label: VRK1
  association: Causative
  subtype: PCH1A
  notes: >
    Homozygous or compound heterozygous loss-of-function mutations in VRK1 (vaccinia-related
    kinase 1) cause PCH1A. VRK1 is a serine/threonine kinase essential for nuclear
    envelope formation that phosphorylates p53 and CREB. Its absence leads to combined
    pontocerebellar and anterior horn cell degeneration (SMA-PCH phenotype).
  evidence:
  - reference: PMID:19646678
    reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "identified a nonsense mutation in the vaccinia-related kinase 1 gene (VRK1) as a cause of SMA-PCH"
    explanation: First identification of VRK1 as the causative gene for PCH1A (SMA-PCH) in human patients.

- name: RARS2 mutations (PCH6)
  gene_term:
    preferred_term: RARS2
    term:
      id: hgnc:21406
      label: RARS2
  association: Causative
  subtype: PCH6
  notes: >
    Biallelic mutations in RARS2, encoding the mitochondrial arginyl-tRNA synthetase,
    impair mitochondrial tRNA charging and oxidative phosphorylation, causing PCH6.
    CSF lactate is typically elevated. Patients may show elevated lactate in blood/CSF
    and reduced respiratory chain complex activity on muscle biopsy.
  evidence:
  - reference: PMID:17847012
    reference_title: "Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "identification of an intronic mutation in RARS2, the gene encoding mitochondrial arginine-transfer RNA (tRNA) synthetase"
    explanation: First identification of RARS2 as the causative gene for PCH6 (mitochondrial aminoacyl-tRNA synthetase deficiency).

- name: EXOSC3 mutations (PCH1B)
  gene_term:
    preferred_term: EXOSC3
    term:
      id: hgnc:17944
      label: EXOSC3
  association: Causative
  subtype: PCH1B
  notes: >
    Biallelic EXOSC3 mutations cause PCH1B, the most common genetically confirmed
    PCH1 subgroup in the referenced cohort. EXOSC3-related disease remains within
    the spinal muscular atrophy-like PCH1 spectrum but shows genotype-dependent
    severity and variable survival.
  evidence:
  - reference: PMID:23284067
    reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Biallelic mutations in EXOSC3 were detected in 10 of 27 families (37%)."
    explanation: Establishes biallelic EXOSC3 variants as causative for a substantial subset of PCH1/PCH1B.

- name: CLP1 mutations (PCH10)
  gene_term:
    preferred_term: CLP1
    term:
      id: hgnc:16999
      label: CLP1
  association: Causative
  subtype: PCH10
  notes: >
    Homozygous CLP1 pathogenic variants cause PCH10 through impaired interaction
    with the TSEN complex and defective pre-tRNA cleavage. The phenotype includes
    severe central nervous system involvement and peripheral sensorimotor
    neuropathy.
  evidence:
  - reference: PMID:24766809
    reference_title: "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Thus, we have identified a defined clinical syndrome with progressive central and peripheral nervous system defects in 11 affected children from five families, all of whom carry a homozygous
      CLP1 R140H mutation."
    explanation: Establishes homozygous CLP1 R140H as causal for a PCH10-related central and peripheral nervous system disorder.

- name: EXOSC8 mutations (PCH1C)
  gene_term:
    preferred_term: EXOSC8
    term:
      id: hgnc:17035
      label: EXOSC8
  association: Causative
  subtype: PCH1C
  notes: >-
    EXOSC8 encodes a structural subunit of the RNA exosome. Biallelic EXOSC8
    variants cause PCH1C, which shares the PCH1 pattern of pontocerebellar
    hypoplasia with anterior horn cell degeneration.
  evidence:
  - reference: PMID:33463720
    reference_title: "Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Bi-allelic variants in exosome subunits EXOSC3, EXOSC8 and EXOSC9 have
      been reported to cause pontocerebellar hypoplasia type 1B, type 1C and
      type 1D, respectively, while those in EXOSC2 cause short stature, hearing
      loss, retinitis pigmentosa and distinctive facies.
    explanation: >-
      Assigns biallelic EXOSC8 variants to PCH1C.
  - reference: PMID:31768969
    reference_title: "The RNA Exosome and Human Disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      mutations in the structural exosome genes EXOSC3 and EXOSC8 cause
      pontocerebellar hypoplasia type 1b (PCH1b) and type 1c (PCH1c),
      respectively, which are related autosomal recessive, neurodegenerative
      diseases.
    explanation: >-
      Confirms EXOSC8 as the PCH1C gene and the autosomal recessive mode.

- name: EXOSC9 mutations (PCH1D)
  gene_term:
    preferred_term: EXOSC9
    term:
      id: hgnc:9137
      label: EXOSC9
  association: Causative
  subtype: PCH1D
  notes: >-
    EXOSC9 encodes a third structural subunit of the RNA exosome. Biallelic
    EXOSC9 variants cause PCH1D, in which cerebellar atrophy is accompanied by
    spinal motor neuronopathy.
  evidence:
  - reference: PMID:33463720
    reference_title: "Bi-allelic missense variant, p.Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Bi-allelic variants in exosome subunits EXOSC3, EXOSC8 and EXOSC9 have
      been reported to cause pontocerebellar hypoplasia type 1B, type 1C and
      type 1D, respectively, while those in EXOSC2 cause short stature, hearing
      loss, retinitis pigmentosa and distinctive facies.
    explanation: >-
      Assigns biallelic EXOSC9 variants to PCH1D.
  - reference: PMID:31768969
    reference_title: "The RNA Exosome and Human Disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      mutations in the structural exosome gene EXOSC9 cause a PCH-like disease
      with cerebellar atrophy and spinal motor neuronopathy.
    explanation: >-
      Describes the EXOSC9 phenotype recorded in this entry.

- name: SLC25A46 mutations (PCH1E)
  gene_term:
    preferred_term: SLC25A46
    term:
      id: hgnc:25198
      label: SLC25A46
  association: Causative
  subtype: PCH1E
  notes: >-
    SLC25A46 encodes a mitochondrial outer-membrane protein regulating
    mitochondrial fission and fusion. Complete loss of function causes the
    lethal congenital PCH1E phenotype; milder alleles of the same gene cause
    optic atrophy and hereditary motor and sensory neuropathy.
  evidence:
  - reference: PMID:27543974
    reference_title: "Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In siblings from two unrelated families who died soon after birth with a
      profound neurodevelopmental disorder characterized by pontocerebellar
      hypoplasia and apnoea, we discovered a missense mutation and an exonic
      deletion in the SLC25A46 gene encoding a mitochondrial protein recently
      implicated in optic atrophy spectrum disorder.
    explanation: >-
      Reports the biallelic SLC25A46 lesions underlying lethal congenital
      pontocerebellar hypoplasia.
  - reference: PMID:40428407
    reference_title: "Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      PCH1 is defined as PCH variant associated with anterior horn degeneration
      in the spinal cord with muscle weakness and hypotonia, and is associated
      with recessive variants in genes VRK1, EXOSC3, EXOSC8, EXOSC9 and
      SLC25A46.
    explanation: >-
      Places SLC25A46 among the recessive PCH1 genes.

- name: TSEN2 mutations (PCH2B)
  gene_term:
    preferred_term: TSEN2
    term:
      id: hgnc:28422
      label: TSEN2
  association: Causative
  subtype: PCH2B
  notes: >-
    TSEN2 encodes a catalytic subunit of the tRNA splicing endonuclease complex.
    Biallelic TSEN2 variants cause PCH2B, a far rarer PCH2 form than the
    TSEN54-associated PCH2A.
  evidence:
  - reference: PMID:41621844
    reference_title: "[Pontocerebellar hypoplasia type 2B due to compound heterozygous variants of TSEN2 gene: A case report and literature review]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Literature review has identified six PCH2B patients with missense,
      nonsense, frameshift, and splice site variants of the TSEN2 gene.
    explanation: >-
      Assigns TSEN2 variants to PCH2B and indicates how few cases are reported.
  - reference: PMID:20803644
    reference_title: "Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Most patients with PCH2 have mutations in TSEN54, with occasional
      mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA
      splicing endonuclease.
    explanation: >-
      Supports TSEN2 as an infrequent PCH2 gene relative to TSEN54.

- name: TSEN34 mutations (PCH2C)
  gene_term:
    preferred_term: TSEN34
    term:
      id: hgnc:15506
      label: TSEN34
  association: Causative
  subtype: PCH2C
  notes: >-
    TSEN34 encodes the second catalytic subunit of the tRNA splicing
    endonuclease complex. Biallelic TSEN34 variants cause PCH2C and, like TSEN2,
    account for only occasional PCH2 cases.
  evidence:
  - reference: PMID:20803644
    reference_title: "Molecular and neuroimaging findings in pontocerebellar hypoplasia type 2 (PCH2): is prenatal diagnosis possible?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Most patients with PCH2 have mutations in TSEN54, with occasional
      mutations found in TSEN34 or TSEN2, genes that encode subunits of tRNA
      splicing endonuclease.
    explanation: >-
      Assigns TSEN34 to PCH2 as an infrequent cause.
  - reference: PMID:18711368
    reference_title: "tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In two subtypes, PCH2 and PCH4, we identified mutations in three of the
      four different subunits of the tRNA-splicing endonuclease complex.
    explanation: >-
      Original report identifying mutations in three TSEN subunits, including
      TSEN34, in PCH2 and PCH4.

- name: TSEN15 mutations (PCH2F)
  gene_term:
    preferred_term: TSEN15
    term:
      id: hgnc:16791
      label: TSEN15
  association: Causative
  subtype: PCH2F
  notes: >-
    TSEN15 encodes the fourth subunit of the tRNA splicing endonuclease complex.
    Biallelic TSEN15 variants cause PCH2F, reported as a milder form of PCH2
    than the TSEN54-associated disease.
  evidence:
  - reference: PMID:27392077
    reference_title: "Autosomal-Recessive Mutations in the tRNA Splicing Endonuclease Subunit TSEN15 Cause Pontocerebellar Hypoplasia and Progressive Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report three homozygous TSEN15 variants that cause a milder
      version of PCH2.
    explanation: >-
      Establishes biallelic TSEN15 variants as a cause of a milder PCH2
      phenotype.

- name: PCLO mutations (PCH3)
  gene_term:
    preferred_term: PCLO
    term:
      id: hgnc:13406
      label: PCLO
  association: Causative
  subtype: PCH3
  notes: >-
    PCLO encodes Piccolo, a presynaptic active zone scaffold protein. A
    homozygous nonsense PCLO variant underlies PCH3, historically described as
    cerebellar atrophy with progressive microcephaly, making PCH3 the one
    synaptic rather than RNA-processing or metabolic PCH mechanism in this
    entry.
  evidence:
  - reference: PMID:25832664
    reference_title: "Loss of PCLO function underlies pontocerebellar hypoplasia type III."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we show that a homozygous, nonsense PCLO mutation underlies the
      autosomal recessive neurodegenerative disorder, PCH3.
    explanation: >-
      Establishes biallelic PCLO loss of function as the cause of PCH3.

- name: TOE1 mutations (PCH7)
  gene_term:
    preferred_term: TOE1
    term:
      id: hgnc:15954
      label: TOE1
  association: Causative
  subtype: PCH7
  notes: >-
    TOE1 encodes a deadenylase that trims the 3' ends of small nuclear RNAs.
    Biallelic TOE1 variants cause PCH7, distinguished from other PCH subtypes by
    genital abnormality, presenting as PCH with a 46,XY disorder of sex
    development in individuals with an XY karyotype.
  evidence:
  - reference: PMID:38605133
    reference_title: "Role of TOE1 variants at the nuclear localization motif in pontocerebellar hypoplasia 7."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Biallelic TOE1 variants can cause pontocerebellar hypoplasia type 7
      (PCH7), a condition characterized by pontocerebellar hypoplasia with
      genital abnormality.
    explanation: >-
      States the TOE1-PCH7 assignment and the distinguishing genital feature.
  - reference: PMID:42178111
    reference_title: "Pontocerebellar hypoplasia linked mutations of the deadenylase Target of EGR1 (TOE1) impair thermal stability, ribonuclease activity, and oligomerization."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We performed characterization of the thermal stability and activity of
      eleven PCH-linked TOE1 variants and found that eight variants have
      significant reduced protein thermal stability and that all but two
      variants impair TOE1's ribonuclease activity, particularly its exonuclease
      activity.
    explanation: >-
      Shows that PCH-linked TOE1 variants reduce the protein's ribonuclease
      activity, supporting loss of function.

- name: CHMP1A mutations (PCH8)
  gene_term:
    preferred_term: CHMP1A
    term:
      id: hgnc:8740
      label: CHMP1A
  association: Causative
  subtype: PCH8
  notes: >-
    CHMP1A encodes a subunit of the ESCRT-III membrane-remodelling complex.
    Biallelic loss of function causes PCH8, reported as reduced cerebellar size
    together with microcephaly. The gene is wired to its own ESCRT-III and
    progenitor-proliferation node rather than being grouped with TBC1D23,
    because no source cited here places CHMP1A in Golgi retrograde transport.
  evidence:
  - reference: PMID:23023333
    reference_title: "CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we show that loss-of-function mutations in human CHMP1A cause
      reduced cerebellar size (pontocerebellar hypoplasia) and reduced cerebral
      cortical size (microcephaly).
    explanation: >-
      Establishes biallelic CHMP1A loss of function as a cause of
      pontocerebellar hypoplasia with microcephaly.

- name: AMPD2 mutations (PCH9)
  gene_term:
    preferred_term: AMPD2
    term:
      id: hgnc:469
      label: AMPD2
  association: Causative
  subtype: PCH9
  notes: >-
    AMPD2 encodes adenosine monophosphate deaminase 2. Biallelic variants
    affecting all isoforms cause the severe early-onset PCH9 phenotype, while
    variants that leave some isoforms intact have been reported in spastic
    paraplegia type 63.
  evidence:
  - reference: PMID:29463858
    reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified homozygous or compound heterozygous AMPD2 variants in eight
      PCH-affected individuals from six families.
    explanation: >-
      Establishes biallelic AMPD2 variants as a cause of pontocerebellar
      hypoplasia.
  - reference: PMID:29463858
    reference_title: "Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The existence of various AMPD2 isoforms with different functions possibly
      explains the variability in phenotypes associated with AMPD2 variants:
      variants leaving some of the isoforms intact may cause SPG63, while those
      affecting all isoforms may result in the severe and early-onset PCH9.
    explanation: >-
      Supports the isoform-dependent split between AMPD2-related SPG63 and PCH9.

- name: TBC1D23 mutations (PCH11)
  gene_term:
    preferred_term: TBC1D23
    term:
      id: hgnc:25622
      label: TBC1D23
  association: Causative
  subtype: PCH11
  notes: >-
    TBC1D23 encodes a Golgi-localised trafficking adaptor required for
    Golgi-based LKB1 signalling. Biallelic TBC1D23 variants cause PCH11, which
    has been reported as a non-degenerative PCH subtype.
  evidence:
  - reference: PMID:40581672
    reference_title: "Identification and functional analysis of a novel TBC1D23 pathogenic variant in a Chinese family with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive
      disorder caused by variants in TBC1D23.
    explanation: >-
      States the TBC1D23-PCH11 gene-disease assignment.
  - reference: PMID:38413626
    reference_title: "TBC1D23 mediates Golgi-specific LKB1 signaling."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      TBC1D23, a Golgi-localized protein that is frequently mutated in the
      neurodevelopment disorder pontocerebellar hypoplasia (PCH), is
      specifically required for the LKB1 signaling at the Golgi.
    explanation: >-
      Sources the Golgi localisation and LKB1 signalling role described here.

- name: COASY mutations (PCH12)
  gene_term:
    preferred_term: COASY
    term:
      id: hgnc:29932
      label: COASY
  association: Causative
  subtype: PCH12
  notes: >-
    COASY encodes CoA synthase, which catalyses the final steps of de novo
    coenzyme A biosynthesis. Near-complete loss of function causes the perinatal
    lethal PCH12 phenotype, while hypomorphic alleles cause COASY
    protein-associated neurodegeneration.
  evidence:
  - reference: PMID:35499143
    reference_title: "COASY related pontocerebellar hypoplasia type 12: A common Indian mutation with expansion of the phenotypic spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Pontocerebellar hypoplasia (PCH) type 12 is a rare, perinatal lethal
      neurodegenerative genetic disorder caused by biallelic mutations in the
      COASY gene.
    explanation: >-
      Establishes biallelic COASY mutation as the cause of PCH12.
  - reference: PMID:39301217
    reference_title: "CoA synthase plays a critical role in neurodevelopment and neurodegeneration."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Recessive variants of this gene cause an exceptionally rare and devastating
      disease called COASY protein-associated neurodegeneration (CoPAN) while
      complete loss-of-function variants in COASY have been identified in
      fetuses/neonates with Pontocerebellar Hypoplasia type 12 (PCH 12).
    explanation: >-
      Supports the allele-severity split between PCH12 and COASY
      protein-associated neurodegeneration.

- name: PPIL1 mutations (PCH14)
  gene_term:
    preferred_term: PPIL1
    term:
      id: hgnc:9260
      label: PPIL1
  association: Causative
  subtype: PCH14
  notes: >-
    PPIL1 encodes a peptidyl-prolyl isomerase component of the major
    spliceosome. Biallelic PPIL1 variants cause PCH14, reported as
    pontocerebellar hypoplasia with microcephaly.
  evidence:
  - reference: PMID:33220177
    reference_title: "Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients harbored biallelic mutations in genes encoding the spliceosome
      components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA
      Processing-17 (PRP17).
    explanation: >-
      Establishes biallelic PPIL1 variants as a cause of pontocerebellar
      hypoplasia with microcephaly.
  - reference: PMID:37190898
    reference_title: "A founder PPIL1 variant underlies a recognizable form of microlissencephaly with pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Biallelic variants in PPIL1 have been recently found to cause a very rare
      type of pontocerebellar hypoplasia and congenital microcephaly in which
      simplified gyral pattern was not observed in all of the patients.
    explanation: >-
      Independent series confirming the PPIL1 gene-disease assignment and
      describing its imaging variability.

- name: MINPP1 mutations (PCH16)
  gene_term:
    preferred_term: MINPP1
    term:
      id: hgnc:7102
      label: MINPP1
  association: Causative
  subtype: PCH16
  notes: >-
    MINPP1 encodes a multiple inositol polyphosphate phosphatase. Biallelic loss
    of function causes PCH16 and allows the chelator inositol hexakisphosphate
    to accumulate intracellularly.
  evidence:
  - reference: PMID:40508022
    reference_title: "Biallelic Loss-of-Function Variant in MINPP1 Causes Pontocerebellar Hypoplasia with Characteristic Severe Neurodevelopmental Disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: >-
      Multiple subtypes of PCH have been identified, among which the rare
      subtype PCH type 16 is caused by MINPP1 genetic variants.
    explanation: >-
      Establishes MINPP1 as the PCH16 gene.
  - reference: PMID:33257696
    reference_title: "MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These data suggest the involvement of IP6-mediated chelation on
      Pontocerebellar Hypoplasia disease pathology and thereby highlight the
      critical role of MINPP1 in the regulation of human brain development and
      homeostasis.
    explanation: >-
      Supports inositol hexakisphosphate accumulation as the proposed
      consequence of MINPP1 loss.

- name: PRDM13 mutations (PCH17)
  gene_term:
    preferred_term: PRDM13
    term:
      id: hgnc:13998
      label: PRDM13
  association: Causative
  subtype: PCH17
  notes: >-
    PRDM13 encodes a transcriptional repressor expressed in cerebellar
    ventricular zone progenitors. Biallelic PRDM13 variants cause PCH17, a fatal
    perinatal brainstem phenotype with cerebellar hypoplasia and disrupted
    Purkinje cell differentiation. A separate PRDM13 phenotype combines
    cerebellar dysfunction with hypogonadotropic hypogonadism.
  evidence:
  - reference: PMID:35390279
    reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe four families with children presenting with severe neonatal
      brainstem dysfunction and pronounced deficits in cognitive and motor
      development associated with four different bi-allelic mutations in PRDM13,
      including homozygous truncating variants in the most severely affected
      individuals.
    explanation: >-
      Establishes biallelic PRDM13 mutation as the cause of this PCH-like
      perinatal phenotype.
  - reference: PMID:35390279
    reference_title: "Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      snRNA-seq data mining and in situ hybridization in humans show that PRDM13
      is expressed at early stages in the progenitors of the cerebellar
      ventricular zone, which gives rise to cerebellar GABAergic neurons,
      including Purkinje cells.
    explanation: >-
      Sources the cerebellar ventricular zone progenitor expression described
      here.

diagnosis:
- name: Neuroimaging and Clinical Subtype Assessment
  description: >
    Brain MRI is central to recognizing PCH, documenting cerebellar and ventral
    pontine hypoplasia, and distinguishing subtype patterns such as the
    TSEN54-related dragonfly-like cerebellar pattern. Serial clinical and imaging
    data help separate prenatal maldevelopment from progressive postnatal
    atrophy.
  diagnosis_term:
    preferred_term: MRI of the brain
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: DOI:10.1093/braincomms/fcaf298
    reference_title: "Pontocerebellar hypoplasia: a review from 1912 to 2022"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It can be diagnosed prenatally or postnatally with a combination of clinical, neuroimaging and genetic data obtained over time."
    explanation: Supports integrated clinical and neuroimaging assessment as part of PCH diagnosis.
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found a strong correlation (P < 0.0005) between TSEN54 mutations and a dragonfly-like cerebellar pattern on magnetic resonance imaging, in which the cerebellar hemispheres are flat and
      severely reduced in size and the vermis is relatively spared."
    explanation: Supports brain MRI as a subtype-informative diagnostic procedure, especially for TSEN54-related PCH2/PCH4.

- name: Molecular Genetic Testing
  description: >
    Multigene panel, exome, or genome testing should evaluate the broad PCH gene
    spectrum and classify subtype-specific causes, including TSEN54/TSEN genes,
    RARS2, VRK1, EXOSC3, and CLP1. Biallelic variant interpretation is essential
    for subtype assignment, recurrence-risk counseling, and prenatal options.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  evidence:
  - reference: DOI:10.1093/braincomms/fcaf298
    reference_title: "Pontocerebellar hypoplasia: a review from 1912 to 2022"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis conveys significant implications for the affected individual and their families and requires a combination of clinical, neuroradiographic, and genetic testing to best inform
      type/subtype categorization of pontocerebellar hypoplasia."
    explanation: Supports genetic testing as a diagnostic requirement for PCH type/subtype categorization.
  - reference: PMID:20301773
    reference_title: TSEN54 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      is confirmed by the presence of biallelic TSEN54 pathogenic variants.
    explanation: >-
      GeneReviews states that biallelic variant detection is what confirms the
      diagnosis in the TSEN54 subtypes.
  - reference: PMID:25144110
    reference_title: EXOSC3 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      is confirmed by the presence of biallelic EXOSC3 pathogenic variants
      identified by molecular genetic testing.
    explanation: >-
      Same confirmation requirement stated for the EXOSC3 subtype, showing the
      rule is not TSEN54-specific.
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The genetic basis of different subtypes has been elucidated, which makes prenatal testing possible in families with mutations."
    explanation: Supports subtype-specific genetic diagnosis and reproductive testing once familial variants are known.

- name: Lactate Testing for RARS2-Related PCH6
  description: >
    Blood and cerebrospinal-fluid lactate testing is useful when PCH6 or another
    mitochondrial PCH presentation is suspected, because elevated lactate supports
    RARS2-related mitochondrial dysfunction while normal lactate does not exclude
    genetically confirmed disease.
  diagnosis_term:
    preferred_term: blood chemistry measurement
    term:
      id: NCIT:C47868
      label: Blood Chemistry Measurement
  evidence:
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Blood and CSF lactate was abnormally elevated in all five patients at early stages"
    explanation: Supports lactate testing as a PCH6-directed biochemical diagnostic clue.

- name: Neuromuscular Electrophysiology for PCH1 and PCH10 Presentations
  description: >
    Electromyography and nerve-conduction studies are appropriate when PCH
    presents with spinal muscular atrophy-like weakness, anterior horn cell
    involvement, or peripheral neuropathy, helping distinguish PCH1 and PCH10
    patterns from primarily central PCH presentations.
  diagnosis_term:
    preferred_term: nerve conduction study
    term:
      id: NCIT:C88502
      label: Nerve Conduction Velocity Test
  evidence:
  - reference: PMID:19646678
    reference_title: "Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The spinal muscular atrophies (SMAs) are a genetically and clinically heterogeneous group of disorders characterized by degeneration and loss of anterior horn cells in the spinal cord, leading
      to muscle weakness and atrophy."
    explanation: Supports neuromuscular evaluation in PCH1A/SMA-PCH presentations with anterior horn cell involvement.
  - reference: PMID:24766809
    reference_title: "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Electrophysiological studies revealed objective evidence for marked axonal sensorimotor neuropathies (Figure 2 and Table S1)."
    explanation: Supports nerve-conduction/electrophysiologic evaluation in CLP1-related PCH10.

- name: Prenatal and Familial Testing
  description: >
    Once familial pathogenic variants are known, prenatal testing or
    preimplantation genetic testing can be considered for future pregnancies in
    affected families, together with carrier testing and counseling for
    autosomal-recessive recurrence risk.
  diagnosis_term:
    preferred_term: chorionic villus sampling
    term:
      id: NCIT:C18020
      label: Diagnostic Procedure
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The genetic basis of different subtypes has been elucidated, which makes prenatal testing possible in families with mutations."
    explanation: Supports prenatal molecular testing once disease-causing familial mutations have been identified.

treatments:
- name: Symptomatic and Supportive Care
  description: >
    No disease-modifying therapy exists for any PCH subtype. Management is supportive:
    nutritional support via nasogastric tube or gastrostomy, respiratory support
    (including mechanical ventilation for severe cases), physiotherapy to manage spasticity
    and contractures, and palliative care. Genetic counselling for families is essential.
    One subtype-specific preventive measure is documented: children with TSEN54-related PCH2
    carry an increased risk of rhabdomyolysis during severe infections, and GeneReviews
    recommends adequate hydration through prolonged high fever to reduce it.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Treatment is only symptomatic and prognosis is poor, as most patients die during infancy or childhood."
    explanation: Confirms that only symptomatic treatment is available and prognosis is poor across PCH subtypes.
  - reference: PMID:20301773
    reference_title: TSEN54 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Children with PCH2 have generalized clonus, uncoordinated sucking and
      swallowing, impaired cognitive development, lack of voluntary motor
      development, cortical blindness, and an increased risk for rhabdomyolysis
      during severe infections.
    explanation: >-
      Names the rhabdomyolysis risk during febrile illness that the hydration
      measure below is directed at.
  - reference: PMID:20301773
    reference_title: TSEN54 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Adequate hydration during prolonged periods of high fever may help avoid
      rhabdomyolysis.
    explanation: >-
      The one specific preventive measure GeneReviews gives for TSEN54-related
      PCH, beyond general symptomatic care.

- name: Feeding and Swallowing Support
  description: >
    Feeding therapy, aspiration-risk assessment, and enteral nutrition by
    nasogastric or gastrostomy tube are important for affected infants with
    dysphagia, hypotonia, failure to thrive, or severe neurodevelopmental
    impairment. This is supportive care and not disease-modifying treatment.
  treatment_term:
    preferred_term: feeding therapy
    term:
      id: NCIT:C156237
      label: Swallowing Therapy
  evidence:
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties."
    explanation: Supports feeding support as a clinically relevant management domain, especially in severe PCH6.
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Treatment is only symptomatic and prognosis is poor, as most patients die during infancy or childhood."
    explanation: Supports supportive management for severe PCH manifestations.

- name: Respiratory Support and Palliative Planning
  description: >
    Respiratory monitoring, noninvasive or invasive ventilation when consistent
    with goals of care, and early palliative-care planning are relevant for
    severe PCH1A/PCH1B, PCH4, and other forms with hypoventilation, ventilator
    dependence, or life-limiting neurologic disease.
  treatment_term:
    preferred_term: palliative care
    term:
      id: NCIT:C15292
      label: Palliative Therapy
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nonsense or splice site mutations in TSEN54 are associated with a more severe phenotype of more perinatal symptoms, ventilator dependency and early death."
    explanation: Supports respiratory support and palliative planning for severe TSEN54-related PCH4.
  - reference: PMID:23284067
    reference_title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Major clinical features previously reported in PCH1, including intrauterine abnormalities, postnatal hypoventilation and feeding difficulties, joint contractures, and neonatal death, were
      rarely observed in mutation-positive infants but were typical among the mutation-negative subjects."
    explanation: Supports respiratory and end-of-life planning for severe PCH1 presentations.

- name: Physical Therapy and Movement-Disorder Care
  description: >
    Physical therapy, positioning, contracture prevention, and symptom-directed
    movement-disorder management address hypotonia, spasticity, dystonia,
    dyskinesia, and progressive motor disability. These interventions are
    supportive and should be individualized by subtype and severity.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  evidence:
  - reference: PMID:20952379
    reference_title: "Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mutations in TSEN54 are clinically associated with dyskinesia and/or dystonia and variable degrees of spasticity, in some cases with pure generalized spasticity."
    explanation: Supports movement-disorder and spasticity-oriented supportive management in TSEN54-related PCH.
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients have severe cognitive and motor handicaps and seizures are often reported."
    explanation: Supports motor-disability-directed supportive therapy across PCH subtypes.
  - reference: PMID:25144110
    reference_title: EXOSC3 Pontocerebellar Hypoplasia.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Contractures and scoliosis are managed by passive or active movement and
      bracing as needed.
    explanation: >-
      Names the specific musculoskeletal measures GeneReviews recommends, which
      this treatment covers.

- name: Antiepileptic Pharmacotherapy
  description: >
    Anticonvulsant medications for management of epileptic seizures in PCH2 and PCH6.
    No specific anticonvulsant is preferred; polytherapy is often required for refractory
    epilepsy in PCH6.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:22569581
    reference_title: "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures."
    explanation: Intractable seizures in PCH6 require anticonvulsant pharmacotherapy, consistent with antiepileptic drug use as a standard management approach.

- name: Genetic Counseling
  description: >
    Genetic counseling should address autosomal-recessive inheritance, recurrence
    risk, carrier testing, molecular confirmation of the familial subtype, and
    reproductive options including prenatal and preimplantation genetic testing
    when familial variants are known.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:21749694
    reference_title: "Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The genetic basis of different subtypes has been elucidated, which makes prenatal testing possible in families with mutations."
    explanation: Supports counseling around molecular subtype, recurrence risk, and prenatal testing options.

clinical_trials:
- name: NCT04378075
  phase: PHASE_II
  status: TERMINATED
  description: >
    Randomized, double-blind, placebo-controlled Phase 2/3 trial evaluating
    vatiquinone (PTC743/EPI-743) for mitochondrial disease with refractory
    epilepsy. Pontocerebellar Hypoplasia Type 6 (RARS2) was listed among the
    eligible conditions in the ClinicalTrials.gov record, making the trial
    relevant to the curated PCH6 subtype.
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: clinicaltrials:NCT04378075
    reference_title: Efficacy and Safety Study of Vatiquinone for the Treatment of Mitochondrial Disease Subjects With Refractory Epilepsy
    supports: SUPPORT
    snippet: >-
      This is a parallel-arm, double-blind, placebo-controlled study with a
      screening phase that includes a 28-day run-in phase to establish baseline
      seizure frequency, followed by a 24-week, randomized, placebo-controlled
      phase.
    explanation: >
      The fetched ClinicalTrials.gov cache supports the trial design and
      seizure endpoint context for vatiquinone in mitochondrial disease with
      refractory epilepsy; the public record lists PCH6 among eligible
      mitochondrial disease conditions.

experimental_models:
- name: PCH2A Patient-Derived Regional Neural Organoids
  description: >
    Human induced pluripotent stem cell lines from individuals homozygous for the
    TSEN54 p.Ala307Ser founder variant were differentiated into cerebellar and
    neocortical organoids. The model recapitulates the region-specific growth deficit
    of PCH2A and supports altered progenitor proliferation kinetics as an early
    neurodevelopmental mechanism.
  experimental_model_type: ORGANOID
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  conditions:
  - TSEN54 p.Ala307Ser homozygous PCH2A
  - control iPSC-derived regional neural organoids
  cell_source: patient-derived induced pluripotent stem cells
  culture_system: regionalized cerebellar and neocortical organoids
  modeled_mechanisms:
  - target: TSEN/CLP1 Dysfunction and Impaired Pre-tRNA Splicing
    description: >
      Recapitulates TSEN54-related, brain-region-specific organoid growth reduction
      and altered neural progenitor proliferation.
    evidence:
    - reference: DOI:10.1242/dmm.050740
      reference_title: "Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences"
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "PCH2a cerebellar organoids were reduced in size compared to controls starting early in differentiation."
      explanation: Shows the organoid model reproduces early cerebellar growth reduction.
  evidence:
  - reference: DOI:10.1242/dmm.050740
    reference_title: "Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences"
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we developed human models of PCH2a using regionalized neural organoids."
    explanation: Establishes a human iPSC-derived organoid model system for PCH2A.

datasets: []

references:
- reference: PMID:20301773
  title: TSEN54 Pontocerebellar Hypoplasia.
  tags:
  - GeneReviews
  findings: []
- reference: PMID:25144110
  title: EXOSC3 Pontocerebellar Hypoplasia.
  tags:
  - GeneReviews
  findings: []
- reference: PMID:23284067
  title: "Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations."
  findings: []
- reference: PMID:24766809
  title: "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function."
  findings: []
- reference: DOI:10.1007/s12311-023-01544-2
  title: Classic "PCH" Genes are a Rare Cause of Radiologic Pontocerebellar Hypoplasia
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: DOI:10.1007/s12311-024-01690-1
  title: "Evaluation of the Patients with the Diagnosis of Pontocerebellar Hypoplasia: A Multicenter National Study"
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: DOI:10.1093/braincomms/fcaf298
  title: "Pontocerebellar hypoplasia: a review from 1912 to 2022"
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: DOI:10.1186/s12920-023-01582-z
  title: A non-coding variant in the Kozak sequence of RARS2 strongly decreases protein levels and causes pontocerebellar hypoplasia
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: DOI:10.1186/s12920-024-01810-0
  title: Broadening the phenotype and genotype spectrum of novel mutations in pontocerebellar hypoplasia with a comprehensive molecular literature review
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: DOI:10.1186/s13023-018-0826-2
  title: What's new in pontocerebellar hypoplasia? An update on genes and subtypes
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: DOI:10.1242/dmm.050740
  title: Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences
  found_in:
  - Pontocerebellar_Hypoplasia-deep-research-falcon.md
  findings: []
- reference: PMID:29903031
  title: "What's new in pontocerebellar hypoplasia? An update on genes and subtypes."
  findings:
  - statement: >-
      Most PCH genes act in RNA processing or translation, which is why this entry
      groups the TSEN complex and RNA exosome subunits into single mechanism nodes.
    evidence:
    - reference: PMID:29903031
      reference_title: "What's new in pontocerebellar hypoplasia? An update on genes and subtypes."
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: >-
        Seventeen PCH-related genes are now listed in the OMIM database, most of
        them have a function in RNA processing or translation.
      explanation: >-
        States that RNA processing and translation is the dominant but not universal
        functional theme across PCH genes.
  - statement: >-
      The PCH classification has been criticised as confusing because it bundles
      non-degenerative and postnatal-onset disorders with the classical prenatal ones.
    evidence:
    - reference: PMID:29903031
      reference_title: "What's new in pontocerebellar hypoplasia? An update on genes and subtypes."
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: >-
        By including such a broad range of phenotypes, including non-degenerative
        and postnatal onset disorders, the current classification gives rise to
        confusion.
      explanation: >-
        Records the reviewers' caveat about the numbered PCH classification this
        entry's has_subtypes list follows.

notes: >-
  PCH encompasses many molecularly defined subtypes sharing prenatal-onset cerebellar
  and pontine hypoplasia; the `has_subtypes` list on this entry enumerates the ones curated
  so far, each anchored to its own MONDO term and causal gene. PCH2E (VPS53) and the
  VPS51-related PCH13 phenotype, and PCH2D (SEPSECS), are curated as separate dismech
  entries rather than as rows here. PCH15 (MONDO:0030259) is not curated anywhere in
  dismech and MONDO records no causal gene for it.
  Key distinguishing features: PCH2 (TSEN54) shows the
  characteristic dragonfly MRI pattern with flat hemispheres and relative vermis sparing,
  progressive microcephaly, and dyskinesia; PCH4 (TSEN54 null alleles) is neonatal lethal;
  PCH1A (VRK1) adds spinal muscular atrophy-like anterior horn cell degeneration; PCH6 (RARS2)
  has elevated CSF lactate reflecting mitochondrial dysfunction. RNA processing and tRNA
  metabolism are central pathogenic themes across subtypes. No curative therapy exists.
  Prognosis is poor with most patients dying in infancy or childhood.

📚